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ABSTRACT
Cells synthesize proteins, the molecular instruments of all cellular processes, via
intermediate biomolecules that are susceptible to damage at every step. Known as the
central dogma of molecular biology, genes encoded in deoxyribonucleic acid (DNA) are
transcribed, spliced, and matured into messenger ribonucleic acid (mRNA). These
nucleic acids direct protein synthesis by the pairing of nucleotide triplets with transfer
RNA (tRNA). tRNAs concomitantly decode the so-called codon, as they escort the
correct amino acid to the ribosome for extension of the nascent polypeptide chain.
Damage to any of these intermediate biomolecules can be highly damaging to protein
synthesis, leading to aberrant biochemical processes, aging, cancer, or apoptosis.
Accordingly, cells have evolved essential response and repair pathways to ensure that
replication, transcription, and translation occur with high fidelity. In this dissertation, we
interrogate two enzymes involved in these quality-control measures: 1) a DNA
glycosylase which recognizes damage to the DNA bases, and 2) a tRNAHis
guanylyltransferase-like protein (or THG1-like proteins, TLPs) which repairs truncated or
mismatched tRNA via 3’5’ polymerization.
DNA is assaulted daily to the tune of 30,000 lesions per cell per day by
exogenous and endogenous stressors. One of many DNA repair pathways, the base
excision repair (BER) pathway, removes the small non-bulky, and oxidized DNA lesions
from the genome. DNA glycosylases are the first enzymes in the concerted mechanism
tasked with scanning the entire genome for DNA damage and initiating the repair of
lesions. The human genome encodes 11 DNA glycosylases, which possess overlapping
substrate specificities within BER. The DNA glycosylase, endonuclease three (Nth),
recognizes and removes oxidized pyrimidines during all phases of the cell cycle. We have
solved the first X-ray crystal structure of human Nth-Like 1 (hNTHL1), which revealed a
novel open conformation. This unprecedented example of an Nth DNA glycosylase
undergoing interdomain rearrangement provides important insight into the molecular
mechanism of this critical guardian of the genome.
In eukaryotes, tRNAs must be modified at the 5’ end during maturation. tRNAHis
guanylyltransferase (THG1), an essential gene in yeast, catalyzes the addition of guanine
to the 5’ end of tRNAHis. Reverse polymerization requires adenylation (or guanylation) to
activate the 5’ end of the tRNA. After adenylation, there is a shift of the 5’-phosphate of
the tRNA to accommodate the forthcoming nucleophilic attack by the 3’-OH of the
incoming nucleotide. In contrast to their human counterparts, the archaeal TLP enzymes
utilize the 3’ to 5’ NTP-polymerization reaction to repair 5’-degraded tRNA molecules.
We have solved the first crystal structure of a TLP caught in an intermediate step
following activation by guanylation, showing that the base rotates within the nucleotide
binding site to align the active site.
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CHAPTER I: INTRODUCTION

1.1 The Central Dogma of Molecular Biology

The central dogma of molecular biology describes the sequential transfer of
information between biopolymers within the cell: DNA to RNA to proteins. DNA, a
robust biomolecule, encodes the blueprint for all of cellular proteins. Histone proteins
accommodate the compaction of DNA into chromatin, which facilitates the packaging of
genomic DNA into chromosomes. The human genome contains 23 pairs of
chromosomes, which provide the hard-copy instructions for protein synthesis.
Chromosomes must be replicated with high fidelity, such that daughter cells receive a full
instruction-set for protein synthesis. Replicative DNA polymerases synthesize genomic
DNA prior to cell division, while other specialized repair polymerases mend breaks and
abnormalities introduced endogenously and exogenously (Steitz and Moore 2017).
Currently, there are 15 known DNA polymerases in the human genome, which can be
divided into five structural families: A, B, X, Y, and archaeo-eukaryotic primase (AEP).
Different DNA polymerases have unique properties essential to their role in protecting
the genome. For example, the replicative DNA polymerases have high fidelity and
processivity, whereas repair DNA polymerases trade fidelity and processivity for the
ability to bypass lesions (Sutton and Walker 2001).
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Genes are transcribed, spliced, and processed into messenger RNA (mRNA), which
serve as an intermediate to protein synthesis. RNA polymerase II, one of five RNA
polymerases (Voet, Voet et al. 2013, Ben-Yishay and Shav-Tal 2019), provides the major
transcription apparatus for translated mRNAs. There are multiple classes of RNA that
have specific functions: mRNA encodes proteins, transfer RNA (tRNA) adds amino acids
to growing protein polypeptide chains, ribosomal RNA (rRNA) conduct catalysis within
the ribosome, and small non-coding RNA (snRNA) regulates protein expression (Voet,
Voet et al. 2013). The wide variety of functions of RNA in cells is under active
investigation.

The ribosome is a ribozyme which translates mRNA into proteins (Steitz and Moore
2017). Proteins are molecules that carry out many essential functions within the cell; they
act as enzymes, scaffolds, and chaperones. The 80S ribosome comprises two subunits in
eukaryotes: the 60S and 40S. The 40S subunit binds mRNA, which occupies a cleft
present in the assembled 80S complex. The Kozak consensus sequence, an essential
signal 5’ to the ATG start site, basepairs to RNA in the 40S subunit, with tRNA-Met
binding the start codon. After this precursor forms, the 60S subunit is recruited, along
with a plethora of initiation factors. The 60S subunit provides additional binding
capabilities for tRNAs, and the nascent peptide exit tunnel. The ribosome imposes
fidelity onto protein synthesis by passing tRNA molecules iteratively through 3 binding
sites via conformational changes pertaining to the relative orientation of the small and
large subunits: Amino-acylated tRNAs enter the A-site, are shuttled to P-site for
2

elongation of the peptide chain, only if the tRNA anticodon complements the bound
codon of the mRNA, and finally arrive at the E-site for exit from the ribosome (Voet,
Voet et al. 2013). The efficacy of pharmacological intervention at the ribosome speaks to
the importance of protein synthesis in terms of cellular viability. Aminoglycosides, a
class of antibiotics encompassing drugs such as kanamycin, neomycin, and streptomycin,
all target the ribosome, leading to premature termination of protein synthesis. A more
recent strategy for ribosome inhibition has been achieved by peptide-based antibiotics,
which clog the peptide exit tunnel (Lin, Zhou et al. 2018). It is therefore critical that
information flow unobstructed from DNA to mRNA to proteins in living cells.

1.1.1

Repair after stalling

During the transfer of information, polymerases and ribosomes can stall because of:
1) physical blockades, such as damaged bases, bound protein obstacles, secondary
structures, 2) depleted nucleotide or amino acid pools, or 3) an improperly folded or
assembled polymerase/ribosome (Edenberg, Downey et al. 2014). Stalled forks during
DNA replication can lead to double-strand breaks (DSBs), which are a highly lethal form
of DNA damage. Stalling during transcription and translation can also lead to damaging
events, albeit less severe, so long as protein synthesis is not obstructed altogether
(Cannan and Pederson 2016).
The type of repair prescribed depends on the precise stalling event, the cell cycle
status, and the step of information transfer underway. During replication and
transcription, the integrity of DNA must remain intact to prevent potentially harmful
3

mutations (Edenberg, Downey et al. 2014). If damage occurs to the DNA while restarting
stalled forks, mutations can become fixed in proliferating cells. Yeast cells have evolved
error-prone mechanisms for replication fork restart, as failure to restart replication forks
would surely result in cell death (Anand, Lovett et al. 2013, Nguyen, Jalan et al. 2015).
The Carr group used variants of the replicative polymerases from Sacchromyces
cerevisiae polymerase δ L591M (Pol δ) and polymerase ε M630F (Pol ε), to attribute the
role of leading strand synthesis to Pol ε and lagging strand synthesis to Pol δ. Pol δ
L591M has a mutator phenotype, and Pol ε M630F can incorporate ribonucleotides,
leading to a unique signature on the newly synthesized strands (Miyabe, Kunkel et al.
2011). More recently, these same polymerase variants were employeed to identifty Pol δ
as the polymerase responsible for fork restart after blocking (Miyabe, Mizuno et al.
2015).
Transcription and translation do not require the same considerations for fidelity, as a
low level of abberant mRNAs is unlikely to kill cells. Proteins are likewise disposable,
although the cell may try to salvage peptides due to the high energy requirements of
translation (Edenberg, Downey et al. 2014). Although another oppurtinity to repair
damaged DNA occurs during transcription. A fatal autosomal recessive disorder,
Cockayne syndrome, arises from mutations in CSA and CSB, leading to a UV sensitive
phenotype. When RNA polymerase II stalls at DNA lesions, CSA and CSB recruit and
initiate nucleotide excision repair (NER), without displacement of the polymerase
(Lagerwerf, Vrouwe et al. 2011).

4

The cell has evolved processes at each step of information transfer, from DNA to
proteins, in order to mitigate damaging events arising at replication, transcription, and
translation. In this dissertation, we investigate the structural biology of an enzyme
involved in the repair of damaged DNA bases thus protecting the genome from
mutations. We also report on a tRNA repair enzyme which ensures a pool of high-quality
tRNA molecules are available for the ribosome during protein synthesis.

1.2

DNA damaging events

There are approximately 30,000 DNA damaging events per human cell per day,
generated by endogenous and exogenous sources (Lindahl 1993, De Bont and van
Larebeke 2004), which must be repaired with high fidelity to maintain the integrity of the
genome. Exogenous sources of DNA damage include, but are not limited to: UV
radiation, gamma radiation, cigarette smoke, and DNA intercalating agents. DNA is also
damaged endogenously by reactive oxygen species (ROS) metabolites and water.
Figure 1 depicts some of the DNA lesions mentioned in the introduction but is not meant
to be a comprehensive list.

1.2.1

Endogenous DNA Damage

Endogenous DNA damage results from normal cellular processes. Enzymes,
proteins, or molecules that interact with DNA can inadvertently lead to DNA damage.
5

For example, DNA polymerases may create a mismatch by incorporating the incorrect
opposite base. Each time a human cell divides, it needs to replicate approximately 3 X
109 bases without error. The replicative polymerases have evolved high fidelity, making
approximately one error per 106-107 bases (Loeb 1991, Loeb and Monnat 2008).
However, other polymerases exhibit lower fidelity and can create mismatches, insertions
or deletions during repair and replication (Loeb and Monnat 2008). Proofreading and
mismatch repair keep single nucleotide polymorphisms (SNPs) accumulation to 10-9-10-10
per cell per replicative cycle (Kunkel 2004, Kunkel 2009, Kunkel 2011). Insertions and
deletions may cause a frameshift, readily inactivating an affected gene. Unrepaired
mismatches or the misincorporation of uracil (U) leads to point mutations during the next
round of replication, which if left unrepaired might lead to cancer and genetic diseases
(Viguera, Canceill et al. 2001, Loeb and Monnat 2008, Potenski and Klein 2014).

Abasic (or apurinic/apyrimidinic, AP) sites are created when then glycosidic bond is
cleaved, either spontaneously by water or catalyzed by a DNA glycosylase.
Approximately 10,000 AP sites are created per human cell per day (Lindahl and Nyberg
1972). Hydrolysis of purines happens at a much greater frequency. Thus this event is
typically termed depurination, although depyrimidination is also prevalent (Lindahl
1993). AP sites which are left unrepaired pose problems for the replicative polymerases.
When a replicative polymerase encounters an AP site, it causes the replication fork to
stall, which may result in a double-strand break (Higuchi, Katayama et al. 2003). DNA
double-strand breaks are especially toxic to cells, because they can result in non-equal
6

segregation of genetic information and chromosomal translocations. Stalled replication
forks become regressed when the nascent DNA re-anneals, generating a four-way
junction. These structures are subject to degradation by structure-specific nucleases or the
MRE11 nuclease, which could bring on deletion of genetic material during replication.

Methyl transferases catalyze the addition of a methyl group to cytosine (C)
creating 5-methyl-cytosine (5mC). The methyl group is donated by Sadenosylmethionine (SAM). SAM can erroneously methylate adenine (A) and guanine
(G), with the most abundant DNA lesion being N7-methylguanine (Rydberg and Lindahl
1982). The most deleterious methylations are O6-methylguanine, O4-methylthymine, and
O4-ethylthymine, which may result in SNPs (De Bont and van Larebeke 2004, Chatterjee
and Walker 2017).

Spontaneous deamination of G, A, C and 5mC occurs primarily in single-stranded
DNA (ssDNA), with C and 5mC being deaminated most readily (Lindahl 1979, Lindahl
1993, Yonekura, Nakamura et al. 2009). Uracil DNA glycosylase quickly excises U
resulting from deamination of C but the product of 5mC, thymine (T) is recognized by
the much slower MMR pathway (Lindahl 1979, Wiebauer and Jiricny 1990, Waters and
Swann 1998). Deamination of 5mC results in GC->AT mutations in CpG islands, and
accounts for approximately one third of SNPs involved in hereditary disease (Cooper and
Youssoufian 1988, De Bont and van Larebeke 2004).
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Over one third of DNA damaging events are caused by oxidation by ROS. ROS
include hydrogen peroxide (H2O2), hydroxyl radical (‧ OH), and superoxide (‧ O2-), with
‧ OH being the most reactive with DNA (Imlay, Chin et al. 1988, Dizdaroglu, Rao et al.
1991). Aerobic metabolism, anabolic processes, catabolic oxidases, and peroxisomal
metabolism generate endogenous ROS (Henle and Linn 1997). At low levels ROS are
used for signaling purposes by the cell but when levels get high DNA, proteins, lipids,
and other biomolecules can be oxidized (Segal 2005). There are many different oxidized
DNA lesions. The most common oxidized base is 8-oxoguanine (8-oxo-G), which is used
as a marker for oxidative stress (Melvin, Cunniffe et al. 1998). 8-oxo-G is particularly
deleterious because it can incorrectly base pairs with A, further burdening the mutation
load (Klungland, Rosewell et al. 1999, Minowa, Arai et al. 2000). Thymine glycol (Tg) is
the most common oxidized pyrimidine, where ‧ OH attacks the C5/C6 double bond of T
or by the deamination of C1 and oxidation C1/C5/C6 of 5mC (Breen and Murphy 1995,
Cao, Jiang et al. 2009, Chatterjee and Walker 2017). There are two chiral centers,
5R6S:5R6R and 5S6R:5S6S cis: trans stereoisomers with the cis isomers being more
prevalent than trans in about equal amounts (Figure 1) (Teebor, Cummings et al. 1987,
Lustig, Cadet et al. 1992, Miaskiewicz, Miller et al. 1993, Vaishnav and Swenberg 1993).
The loss of planarity of the ring in Tg can stall the replicative polymerases increasing the
detrimentally of the lesion (Ide, Kow et al. 1985, Clark and Beardsley 1986, Clark and
Beardsley 1987, Kao, Goljer et al. 1993, Hatahet, Kow et al. 1994, Aller, Rould et al.
2007). ROS can also create AP sites by attacking the N-glycosidic bond and create
single-strand breaks in the DNA backbone (Henner, Grunberg et al. 1983).
8

1.2.2 Exogenous DNA Damage

Ionizing radiation (IR) can directly or indirectly cause oxidative damage, singlestrand breaks (SSB) or double strand breaks (DSB). Indirectly IR can react with water
molecules forming ‧ OH radicals, accounting for ~65% of radiation-induced damage,
resulting in oxidation events (Vignard, Mirey et al. 2013). IR tends to result in clusters of
lesions, which can generate DSBs during the repair process. DSBs are considered the
most lethal damaging event because of the severity and difficulty of high-fidelity repair.

The sun emits ultraviolet (UV) radiation in the form of UV-A, UV-B, and UV-C.
UV-C is absorbed by DNA with a higher efficiency than UV-A or UV-B, but is mostly
absorbed by the ozone layer in the Earth’s atmosphere (Davies 1995). UV exposure
primarily leads to crosslinked-pyrimidines but can also result in SSBs, bulky DNA
adducts, and oxidized bases (Friedberg 2005).

Exposure to chemicals found in cigarette smoke, chemotherapy drugs, pesticides,
dyes, etc. can damage DNA (Chatterjee and Walker 2017). Intrastrand crosslinking
events, adduct formation, and alkylation are the main DNA lesions observed. The
chemicals can either directly damage the DNA via a transfer (alkylation) or intercalate in
the DNA (Friedberg 2005).

9

1.3 DNA Repair Pathways

Genetic diversity occurs from mutations of genes, and whether the mutations are
helpful or harmful is determined by natural selection (Charlesworth, Morgan et al. 1993).
The rate of new mutations varies across the genome and is influenced by DNA sequence
and recombination rate (Eyre-Walker 1993, Hellmann, Ebersberger et al. 2003). If these
mutations occur within non-coding regions of the genome, then they are most likely
nondamaging and therefore a silent mutation. If genes are mutated, these events can be
deleterious. A SNP can be silent (codes for the same amino acid due to degenerate
codons), missense (changes the amino acid), or nonsense (causes early termination, or a
frameshift by either an insertion or deletion of a base) (Voet, Voet et al. 2013).

The cell has developed multiple concerted pathways to repair damaged DNA with the
highest possible fidelity, in order to prevent mutations in the genome, and prevent further
damage called the DNA damage response (DDR) (Jackson and Bartek 2009). Small, nonbulky DNA lesions, such as oxidation and alkylation, missing bases and single-strand
breaks are repaired by the base excision repair (BER) pathway. BER is initiated by DNA
glycosylases to recognize and excise the lesion, then a nuclease, polymerase and ligase
repair the DNA strand (Zharkov 2008, Wallace 2014). The nucleotide excision repair
(NER) pathway removes large, bulky DNA lesions, adducts, and crosslinks from the
DNA, but with dozens more proteins required than BER (Hoeijmakers 2001, Shuck,
Short et al. 2008). The mismatch repair (MMR) pathway recognizes when the incorrect
10

base, insertions or deletions occur by the polymerase. The DNA is nicked and then a
nuclease, polymerase and ligase finish the repair (Jiricny 2006). Lastly, double-strand
breaks are repaired by one of three pathways: homologous recombination (HR), nonhomologous end joining (NHEJ), and microhomology mediated end joining (MMEJ). HR
employs the sister chromatid to repair the DSB in an error-free manner. NHEJ and
MMEJ are error-prone pathways, but due to the severity of DSBs, it is in the best interest
of the cell to repair the DNA in any way possible. NHEJ simply joins the two broken
ends together, potentially leading to large insertions or deletions. MMEJ searches for
short regions of homology to rejoin the DNA (Ceccaldi, Rondinelli et al. 2016). All of the
DSB repair pathways require many proteins in coordination to mend the break. Figure 2
summarizes the DNA repair pathways.

1.4 The Base Excision Repair Pathway

The base excision repair (BER) pathway is the primary mechanism for removing
oxidized DNA lesions. In short patch (SP) BER a single base is removed and replaced,
whereas in long patch BER two or more nucleotides are removed (Figure 3) (Dianov,
Price et al. 1992, Frosina, Fortini et al. 1996, Klungland and Lindahl 1997). DNA
glycosylases are the enzymes that initiate the BER pathway by probing, recognizing, and
excising DNA lesions. They can be divided into two groups, monofunctional and
bifunctional. The monofunctional DNA glycosylases possess only glycolytic activity,
leaving an abasic site upon removal of the DNA lesion. SP-BER is initiated by the
11

bifunctional DNA glycosylases, which have glycosylase and lyase activity, nicking the
DNA backbone either once (β-elimination, leaving a 3’-aldehyde) or twice (β-δelimination, leaving a 3’phosphate) creating a SSB (Dianov, Bischoff et al. 1998, Fortini,
Parlanti et al. 1999). Apurinic endonuclease 1 (APE1) or polynucleotide kinase (PNK),
process the glycosylase products respectively, leaving a free 3’ hydroxyl for polymerase
β (Polβ) to insert the correct opposite base. The nick is sealed by the DNA ligase IIIα
(LIGIII) and X-ray repair cross complimenting 1 (XRCC1) complex (Cappelli, Taylor et
al. 1997). If the glycosylase was monofunctional LP-BER is most likely to occur, with
the lyase activity of APE1 nicking the backbone (Fortini, Parlanti et al. 1999). The SSB is
then resected and Polβ probably inserts the first nucleotide before either of the replicative
DNA polymerases takes over (Podlutsky, Dianova et al. 2001). After excision of the
lesion by the DNA glycosylase, LP-BER requires replication factor -C to load
proliferating cell nuclear antigen (PCNA), the sliding clamp for polymerase β, δ, or ε
onto the DNA. Flap endonuclease (FEN1) trims the excess DNA and DNA ligase I seals
the nick (Cappelli, Taylor et al. 1997, Pascucci, Stucki et al. 1999). Monofunctional DNA
glycosylases tend to initiate LP-BER, while the bifunctional glycosylases lead to SPBER.

1.4.1 Coordination of Enzymes within BER

The BER pathway is thought to be a concerted mechanism where there is a “hand
off” between enzymes in sequential steps (Wilson and Kunkel 2000, Prasad, Shock et al.
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2010). The DNA glycosylases have high affinity for their product and remain bound to
the highly reactive AP site until APE1 arrives (Sung and Mosbaugh 2000, Hill, Hazra et
al. 2001, Privezentzev, Saparbaev et al. 2001, Vidal, Hickson et al. 2001). The hand off
to APE1 can either occur through a protein-protein interaction, or by DNA steric strain
dislodging the DNA glycosylase (Waters, Gallinari et al. 1999, Mol, Izumi et al. 2000).
XRCC1 has been shown to interact with APE1, PNK, Polβ, and PCNA (Kubota, Nash et
al. 1996, Vidal, Hickson et al. 2001, Whitehouse, Taylor et al. 2001, Fan, Otterlei et al.
2004). It has been shown that Polβ will bind to the APE1 reduced AP site and recruit
LigIIIα to seal the nick (Parsons, Dianova et al. 2005). The “BERosome” likely does not
scan the DNA as a complex but rather the transient interactions aid in recruitment of the
downstream enzymes protecting the cells from potentially lethal intermediates (Boiteux
and Guillet 2004, Simonelli, Narciso et al. 2005).

1.5 DNA Glycosylases

DNA glycosylases are tasked with the unimaginable job of searching the entire
genome for DNA lesions, recognizing the damaged base, and removing it from the DNA
strand. DNA glycosylases encounter undamaged bases 30,000 times more frequently than
damaged bases, meaning that the enzymes need to be highly selective in damaged base
recognition and removal (Friedman and Stivers 2010). The human genome has ~7x109
base pairs and there are ~105 DNA glycosylases per cell meaning that each glycosylase
needs to scan 70,000 base pairs (Cappelli, Hazra et al. 2001). Considering our mutational
13

burden is much lower than the 30,000 DNA damaging events per cell per day that occur
(Lindahl 1993, De Bont and van Larebeke 2004), DNA glycosylases have evolved to be
efficient at searching the genome (Friedman and Stivers 2010). There are four structural
super families of DNA glycosylases: Udg, Nth, Nei, and AGG (Brooks, Adhikary et al.
2013). Each superfamily has two domains or folds, that are unique to each family, and
create a non-specific DNA binding cleft (Figure 4). DNA glycosylases use an induced fit
mechanism called base flipping, or “pinch, push, plug, and pull” (Slupphaug, Mol et al.
1996, Jiang and Stivers 2002, Jiang, Stivers et al. 2002). AlkD is the exception because it
adopted a non-base-flipping mechanism (Mullins, Shi et al. 2015). The DNA is
“pinched” or kinked by the enzyme, thereby destabilizing the helix (Jiang and Stivers
2002). The DNA glycosylases that evert the damaged base use a wedge residue to probe
the DNA and “push” the DNA lesion out of the helix (Jiang and Stivers 2002, Dunn, Kad
et al. 2011). One to three protein residues move into the space vacated by the everted
base to stabilize the DNA backbone (Jiang and Stivers 2002).

1.5.1 The Udg Family

The Udg family comprises the monofunctional glycosylases, Uracil DNA
glycosylase (Udg), Thymine DNA glycosylase (Tdg), and single-stranded
monofunctional uracil DNA glycosylase (SMUG1). The Udg family has a conserved α/β
fold that forms a positively charged channel for binding DNA (Figure 4) (Mol, Arvai et
al. 1995). Incorporation of dUTP into the genome or deamination of cytosine to uracil
can be mutagenic if not repaired.
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Lindahl identified the first DNA glycosylase in E. coli, Udg. Udg recognizes U:A
and U:G with high affinity. The DNA helix is severely distorted by Udg binding, and the
plug residue, leucine, is inserted into the DNA to stabilize the DNA helix as the uracil
“flips out” into the highly specific active site of Udg. The active site is too small to
accommodate a purine, thymine is discriminated by a tyrosine residue, and cytosine is
unable to make the specific hydrogen bonds with the uracil binding motif.

Tdg, SMUG1, and mismatch specific thymine glycosylase (MBD4) also
recognize uracil in the genome. MBD4 has an N-terminal methyl-CpG-binding domain
(MBD) and C-terminal glycosylase domain that belongs to the HhH family of
glycosylases, whose fold will be described in the next section (Hendrich, Hardeland et al.
1999). Tdg and MBD4 have been implicated in epigenetic homeostasis by removing
mispaired T:G from APOBEC- and AID-dependent deamination of 5mC (Rai, Huggins et
al. 2008, Cortazar, Kunz et al. 2011, Cortellino, Xu et al. 2011). Tdg is also able to
remove 5mC oxidation products generated by ten-eleven translocation (TET) proteins,
5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine
(5caC) (Maiti and Drohat 2011, Zhang, Lu et al. 2012, Hu, Zhang et al. 2014). Tdg binds
and kinks the DNA much like Udg but uses an arginine as a plug residue instead of
leucine, and two lysine residues interact with the non-damaged strand DNA backbone.
Much like Udg, the DNA lesions are recognized in the active site via hydrogen bonding.
The specificity for removing the incorrect T:G and not T:A is due to several contacts with
the guanine opposite the thymine (Waters and Swann 1998).
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SMUG1 is suggested to have evolved from an Udg gene duplication as it is only
present in higher eukaryotes (Haushalter, Todd Stukenberg et al. 1999, Aravind and
Koonin 2000). Murine udg-/- cells do not exhibit the same mutator phenotype as E. coli
and S. cerevisiae because SMUG1 can remove the spontaneous deaminated cytosines
(Nilsen, Rosewell et al. 2000). Initially SMUG1 was believed to only remove uracil in
ssDNA but it has since been shown to act on dsDNA as long as APE1 is present
(Haushalter, Todd Stukenberg et al. 1999, Nilsen, Haushalter et al. 2001).

1.5.2 The HhH or Nth family

Endonuclease III (Nth), 8-Oxoguanine DNA glycosylase (OGG1), MUTYH,
MBD4 and AlkA belong to the helix-hairpin-helix (HhH) superfamily. Nth is the
founding member of the HhH superfamily, thus it may also be referred to as the Nth
family (Thayer, Ahern et al. 1995). This family consists of two globular α-helical
domains with the DNA binding cleft being formed between the two domains (Figure 4)
(Thayer, Ahern et al. 1995, Fromme and Verdine 2003). The HhH/GPD domain
comprises a HhH DNA binding motif characterized by a glycine and proline rich loop
and a conserved aspartate (Denver, Swenson et al. 2003). This domain makes hydrogen
bond interactions with the DNA backbone, contains a bulky plug residue and the wedge
residue. The other domain is less conserved; it can harbor an iron-sulfur cluster, a zinc
ion, or a carbamylated lysine (Thayer, Ahern et al. 1995, Denver, Swenson et al. 2003,
Rubinson, Gowda et al. 2010).
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Nth and Ogg1 are bifunctional glycosylases, possessing both glycolytic and βelimination activity on the DNA backbone, thus leaving a 3’ aldehyde and a 5’ phosphate
flanking the single strand break. Wallace first discovered EndoIII (Nth) in E. coli
(Strniste and Wallace 1975). Nth recognizes a broad spectrum of oxidized pyrimidines
due to a highly polar active site, with Tg being the preferred substrate (Fromme and
Verdine 2003, Miller, Fernandes et al. 2004). Ogg1 discriminates between guanine and 8oxo-G by a single hydrogen bond between the protonated N7 of 8-oxo-G and the
carbonyl oxygen of Gly42 (Radom, Banerjee et al. 2007, Lee, Radom et al. 2008,
Crenshaw, Nam et al. 2012).

MutY and MBD4 are monofunctional glycosylases possessing only glycolytic
activity. If 8-oxoG is left unrepaired adenine will be incorporated opposite during
replication, which can result in GC->TA transversions. MutY recognizes and removes the
adenine opposite 8-oxoG giving OGG1 a second chance at repair (Nghiem, Cabrera et al.
1988, Tominaga, Ushijima et al. 2004). The HhH domain contains the adenine-binding
pocket, which contacts the purine via specific interactions (Nghiem, Cabrera et al. 1988,
Tominaga, Ushijima et al. 2004, Lee and Verdine 2009). The C-terminal domain contains
an iron-sulfur cluster [4Fe4S] and makes contacts with the 8-oxoG that are necessary for
recognition of the 8-oxoG-A mispair and removal of adenine (Livingston, O'Shea et al.
2008).

1.5.3 H2TH or Fpg/Nei Family
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Like the previously described families, the glycosylases of the H2TH family form
the DNA binding cleft between two globular domains with both α and β secondary
structure characteristics. The N-terminal domain is a β-sandwich bordered with α-helices.
Both DNA binding motifs are located in the C-terminal domain: 1) the helix-two-turnhelix (H2TH), and 2) the Zinc or Zinc-less finger motif (Figure 4) (Prakash, Doublie et
al. 2012). The human Nei-like 1 (NEIL1) crystal structure revealed the surprising Zincless finger, which has since been observed in Mimivirus Nei1 and the plant and fungal
Fpg DNA glycosylases (Doublie, Bandaru et al. 2004, Imamura, Wallace et al. 2009,
Duclos, Aller et al. 2012). The H2TH DNA glycosylases share structural and catalytic
conservation but lack overall sequence conservation. These DNA glycosylases are
bifunctional with glycolytic and β-δ- lytic activity, leaving a 3’ and 5’ phosphate flanking
the single-strand break.

In humans the NEIL1, NEIL2, and NEIL3 have been implicated in processes
other than non-canonical BER. NEIL1 exhibits a substrate preference for oxidized
pyrimidines, as well as the further oxidation products of 8-oxo-G, spiroiminodihydantoin
(Sp) and 5-guanidinohydantoin (Gh). NEIL2 and NEIL3 exhibit a preference for ssDNA,
bubbled, or forked DNA substrates of dsDNA (Prakash, Doublie et al. 2012, Mullins,
Rodriguez et al. 2019). NEIL1 and NEIL3 have also shown the ability to repair psoralen
cross-links. Psoralen crosslinks in triplex DNA can be unhooked by NEIL1, while NEIL3
has activity on psoralen and AP site crosslinks at replication forks (Couve-Privat, Mace et
al. 2007, Couve, Mace-Aime et al. 2009, Semlow, Zhang et al. 2016). Unlike NTHL1
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(Nth-Like protein 1) and OGG1, NEIL1 and NEIL3 are cell-cycle dependent, being
expressed during DNA replication in S phase (Torisu, Tsuchimoto et al. 2005,
Hildrestrand, Neurauter et al. 2009, Neurauter, Luna et al. 2012). NEIL2 has been shown
to interact with the transcription machinery (Hazra, Kow et al. 2002, Dou, Mitra et al.
2003, Banerjee, Mandal et al. 2011). Lastly, NEIL2 and NEIL3’s preference for ssDNA,
bubble, and forked substrates suggests involvement in replication (Dou, Mitra et al. 2003,
Liu, Bandaru et al. 2010, Liu, Imamura et al. 2013). Taken together, all of the evidence
incriminates NEIL1 and NEIL3 in replication-coupled repair, and NEIL2 in transcriptioncoupled repair, suggesting that there is much more to the story than serving as backup to
NTHL1 and OGG1 (Mullins, Rodriguez et al. 2019).

1.5.4 The AAG Family

Alkyladenine glycosylase (AAG, also known as N-methylpurine-DNA
glycosylase or MPG) removes alkylated and methylated purines, as well as hypoxanthine
(HX). AAG is a monofunctional glycosylase (McCullough, Dodson et al. 1999, Wyatt,
Allan et al. 1999, Metz, Hollis et al. 2007, Sedgwick, Bates et al. 2007). Unlike the
previously described superfamilies, the crystal structure of AAG revealed that there is a
single domain with both α and β character (Figure 4). The tyrosine plug residue is located
within the positively charged DNA binding surface, and another tyrosine and methionine
stabilize the everted base. Further separating AAG from the previous glycosylases, an
activated water molecule initiates cleavage of the glycosidic bond (Lau, Scharer et al.
1998). Setser et. al crystallized AAG in two states on DNA, a high affinity state and a
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low affinity state. In the low affinity conformation, the residues that form the top of the
active site are ordered and the active site floor residues are disordered. Sester et al.
suggest that this is what allows the DNA glycosylase to search the DNA, and upon
finding the DNA lesion the active site becomes ordered and is more tightly bound to the
DNA (Setser, Lingaraju et al. 2012).

1.5.5 Conformational Changes in DNA Glycosylases

DNA glycosylases were thought to be relatively rigid enzymes, with only
interdomain changes, as the apo- and DNA-bound forms are nearly identical as shown by
the crystal structures where both forms are available (Figure 5). There are two currently
known exceptions by X-ray crystallography: UDG exhibits a 10o shift between the apoand DNA-bound forms (Parikh, Mol et al. 1998, Kuznetsov, Kladova et al. 2015), and
EcoNei undergoes a more dramatic 50o rotation upon DNA binding (Zharkov, Golan et
al. 2002, Golan, Zharkov et al. 2005) (Figure 5). These are more dramatic rearrangements
of the DNA glycosylase than seen in the AAG high and low affinity models, although
AAG has yet to be crystallized without DNA, and are intriguing for DNA lesion
searching and recognition by DNA glycosylases (Setser, Lingaraju et al. 2012). AAG is
also a single domain protein, so large interdomain changes are impossible. The 50o
rotation in EcoNei was unexpected but has been attributed to a flexible hinge region that
connects the two domains (Golan, Zharkov et al. 2005). Although this conformational
change was surprising, there are many examples of flexibility in DNA binding proteins,
including DNA polymerases and transcription factors. The conformational change of
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UDG has been described as a “pinching in” of three serine/proline-rich loops, most likely
due to a flexible hinge region between the two folded domains (Parikh, Mol et al. 1998).
In both EcoNei and UDG the N- and C- termini domains/folds are similar when unbound
or bound to DNA, but rather their orientation in space is different with a more open apoconformation and closed conformation when bound to DNA.

The H2TH structural superfamily has been well studied using solution techniques
to study conformational changes. The Zharkov group identified the conformation change
observed in the EcoNei crystal structures using intrinsic tryptophan fluorescence (Trp
fluorescence). They identified three reversible steps before the irreversible chemistry step
and product release: The first large reversible step can be attributed to the closing of the
enzyme, and the last two steps are due to DNA conformational changes identified using
fluorescent reporters (Zharkov, Golan et al. 2002, Kuznetsov, Koval et al. 2012,
Kladova, Kuznetsova et al. 2017). Although the crystal structures of Arabidopsis thaliana
Fpg do not show interdomain rearrangement, large changes in stopped-flow fluorescence
of intrinsic tryptophans have been observed while EcoFpg processes DNA lesions in
solution, further suggesting overall gross conformational changes of DNA glycosylases
(Fedorova, Nevinsky et al. 2002, Duclos, Aller et al. 2012). Using the intrinsic Trp
fluorescence and well-placed dyes in the DNA helix, five reversible steps before the
irreversible chemistry step and product release were identified. 1) non-specific DNA
binding, 2) Phe110 insertion which destabilizes the DNA, 3) DNA kinking, 4) eversion of
the DNA lesion into the active site with void filling by Arg 108 and Met 73, and 5)
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isomerization of the enzyme (Fedorova, Nevinsky et al. 2002, Koval, Kuznetsov et al.
2004, Kuznetsov, Koval et al. 2007, Kuznetsov, Zharkov et al. 2009, Koval, Kuznetsov et
al. 2010, Kuznetsov, Vorobjev et al. 2012). Human NEIL1 is the most recent DNA
glycosylase where interdomain rearrangement has been observed by Trp fluorescence and
FRET. NEIL1 was determined to behave more like Nei than Fpg, except that there was a
fourth reversible step during recognition of DHU, not seen in Nei. There were only 3
conformational rearrangements in the recognition of an AP site, suggesting that there is
addition adjustment of the damaged base (Kladova, Grin et al. 2019). Multiple enzymes
from bacterial to humans in the H2TH superfamily have shown large enzyme
isomerization, suggesting that the DNA glycosylase rearrangements are critical for
substrate recognition.

In the HhH structural superfamily human OGG1 and EcoNth conformational
changes have been investigated in solution. The crystal structures of human OGG1 and
bacterial Nth do not show interdomain rearrangements. Kuznetsov et al identified three
pre-excision steps in OGG1 using the same methods used with the H2TH family enzymes
(Kuznetsov, Koval et al. 2005, Kuznetsov, Koval et al. 2007, Kuznetsov, Koval et al.
2011, Kuznetsov, Kuznetsova et al. 2014, Kuznetsova, Kuznetsov et al. 2014,
Tyugashev, Vorobjev et al. 2019). The three steps are: 1) initial non-specific DNA
binding, 2) insertion of residues involved in lesion recognition, and 3) OGG1
isomerization (Kuznetsov, Koval et al. 2007). During the recognition step of DNA
binding arginines 154 and 204 probe the DNA, and Tyr 203 intercalates the DNA to
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stabilize the helix (Kuznetsova, Kuznetsov et al. 2014). The catalytic residues Lys 249
and Asp 268 have also been implicated in adjusting the enzyme to obtain the optimal
conformation for catalysis (Tyugashev, Vorobjev et al. 2019). Stopped-flow fluorescence
of EcoNth showed rearrangement of residues in the active site during lesion recognition,
removal and release. This group was unable to detect large movements in the Trp
fluorescence suggesting that either EcoNth does not undergo large conformational
changes or that the buffer quenched the signal but show two phases in DNA lesion
recognition (Kuznetsov, Kladova et al. 2015). Further investigation of EcoNth using
point mutations identified the first step as the wedge residue Leu 81 probing the DNA,
and the second phase is due to Leu 81 and Gln 41 filling the void left by the everted base.
Kladova et al. also show that the catalytic Lys 120 is involved in discrimination between
damage and undamaged DNA, and the catalytic Asp 139 is necessary to distort the DNA
helix (Kladova, Krasnoperov et al. 2018).

Single-molecule techniques investigating DNA glycosylases searching for lesions,
have shown the importance of an intradomain conformational change involving the
wedge residue. When the wedge residue is mutated so that the DNA glycosylase can no
longer probe the DNA, the enzyme moves much faster and does not stop on DNA lesions
(Dunn, Kad et al. 2011, Nelson, Dunn et al. 2014, Lee and Wallace 2017). These data
suggest that the “high affinity” state (think AGG crystals) is unable to be reached without
the wedge residue. This highlights the importance of the more minute, intradomain
rearrangements of the DNA glycosylases for lesion searching and catalysis.
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The X-ray crystallography and solution studies of DNA glycosylases highlight the
importance of conformational changes in lesion recognition and removal. All DNA
glycosylases studied have shown intradomain reorganization is necessary in the “pinch,
push, plug, pull” model. Some of the glycosylase have more dramatic interdomain
changes, which may be present in all classes of life (H2TH family) or may only be
present in some (HhH family). This dissertation presents the first example of flexibility in
hNTHL1, a member of the HhH family of DNA glycosylases. Reorganization of DNA
glycosylases appears to play an important role during the DNA lesion search and
recognition, with conformational changes in DNA observed across all the DNA
glycosylase superfamilies in bacteria and mammals.

1.6 Nth DNA Glycosylase

1.6.1 Structure

There are currently only bacterial crystal structures of Nth. The first bacterial Nth
crystal structure, EcoNth, revealed that the enzyme consists of two globular domains
composed of all α-helices, the six-helical barrel domain and the [4Fe4S] cluster domain
This crystal structure identified the first HhH motif containing glycosylase, and the first
[4Fe4S] cluster in a DNA binding protein (Kuo, McRee et al. 1992, Kuo, McRee et al.
1992, Cunningham, Ahern et al. 1994, Thayer, Ahern et al. 1995). The six-helical barrel
domain contains the HhH motif. Geobacillus stearothermophilus Nth was crystallized in
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the presence of DNA in two forms, bound to the non-hydrolysable AP site analog,
tetrahydrofuran, and covalently trapped via a Schiff base. These structures showed that
DNA binds along the cleft between the two domains, with the nucleophilic lysine in the
six-helical barrel domain, and the aspartate in the [4Fe4S] cluster domain that
deprotonates the lysine. The Nth-DNA bound models also elucidated the extensive
contacts of the [4Fe4S] domain to the DNA backbone (Fromme and Verdine 2003). The
most recent Nth structures are from Deinococcus radiodurans, an extremophile which
possesses three isoforms of Nth. One of the isoforms has an N-terminal extension
reminiscent of the human NTHL1. This study showed that the isoforms of DraNth have
differences in activity but the overall structure of DraNth are similar to the previously
published bacterial Nth structures (Sarre, Okvist et al. 2015). Further investigation of the
DraNth homologs revealed that DraNth1 prefers ssDNA, DraNth2 is the most robust at
removing pyrimidines from dsDNA, and DraNth3, with the N-terminal extension, has no
observed glycosylase activity but likely binds and protects AP sites (Sarre, Stelter et al.
2019).

1.6.2 Potential Role of the [4Fe4S] Cluster

The [4Fe4S] cluster is necessary for activity and the Barton group has suggested
that it is involved in scanning the DNA for lesions using DNA charge transfer
(CT)(Boon, Livingston et al. 2003, Lukianova and David 2005, Boal, Genereux et al.
2009). These authors have shown that Nth and other [4Fe4S] containing enzymes bind
DNA with higher affinity in the presence of H2O2, thus inferring that the [4Fe4S] DNA
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repair enzymes can sense and respond to oxidative stress (Boal, Genereux et al. 2009).
More recently they have shown that electrochemically oxidizing the [4Fe4S] cluster of
Nth from [4Fe4S]2+ to [4Fe4S]3+ results in more Nth bound to the DNA and when they
introduced a mismatched C:A into the DNA strand more Nth remained bound because
the DNA CT was disrupted (Tse, Zwang et al. 2017). The hypothesis is that when the
electrons can move freely along the DNA they will reduce the [4Fe4S] of Nth, thus
decreasing the affinity for the DNA, allowing the glycosylase to release and begin
searching elsewhere. But if the DNA CT is inhibited then the cluster will remain oxidized
and Nth will stay bound and continue searching for the DNA lesion. It should be noted
that the idea that cells may use electricity to repair DNA is not without controversy
(Service 2014).

1.6.3 Tg Removal by Nth

Tg is a deleterious oxidized lesion which blocks high-fidelity DNA polymerases
(Ide, Kow et al. 1985, Clark and Beardsley 1986, Clark and Beardsley 1987, Kao, Goljer
et al. 1993, Hatahet, Kow et al. 1994, Aller, Rould et al. 2007). DNA polymerase α does
not have stereospecificity and is stalled by both isomers, whereas DNA polymerase η
bypasses the (5R,6S) isomer more efficiently and DNA polymerase κ handles the (5S,6R)
Tg isomer better (Fischhaber, Gerlach et al. 2002, Kusumoto, Masutani et al. 2002). Tg
has been found to be both non-mutagenic and lethal in bacteria due to the stereoisomers
creating an interesting paradigm of lesion toxicity and stereoselectivity (Basu, Loechler et
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al. 1989, Wallace 2002). With varying results, stereoselectivity must be considered and
controlled for with isolation of the individual stereoisomers (Wang 2002).

Due to the redundancy of DNA glycosylases in the BER pathway the E. coli nth
mutant is a weak mutator when damage is induced by either H2O2 or X-irradiation,
whereas the nth nei mutant has a strong mutator phenotype, with overwhelmingly G:C ->
A:T transitions (Jiang, Hatahet et al. 1997, Saito, Uraki et al. 1997). It has been suggested
that EcoNei is a backup for EcoNth, but their stereoselectivity for Tg is complimentary
(Melamede, Hatahet et al. 1994, Wallace, Bandaru et al. 2003, Miller, Fernandes et al.
2004). EcoNth cleaves the (5R-6S) stereoisomer with about 10-fold greater efficiency
(Miller, Fernandes et al. 2004). S. cerevisiae has two Nth homologs, Ntg1 and Ntg2
(Eide, Bjoras et al. 1996, Alseth, Eide et al. 1999). Ntg1 is induced by H2O2, while Ntg2
is a housekeeping gene (Eide, Bjoras et al. 1996, You, Swanson et al. 1998). If either
gene is deleted there is an increased mutational burden (Alseth, Eide et al. 1999). Ntg1
displays stereoselectivity, preferring the (5S-6R) isomer, while Ntg2 does not have
stereoselectivity and excises the majority of Tg in yeast (Miller, Fernandes et al. 2004).
An NTHL1 knockout in mice identified three other DNA glycosylases that recognize
oxidized pyrimidines, one of them being mNEIL1. Both mNTHL1 and mNEIL1 prefer
the (5S-6R) stereoisomer, with mNEIL1 having about 10-fold greater efficiency of
excision (McTigue, Rieger et al. 2004, Miller, Fernandes et al. 2004). Interestingly,
studies with mouse cell extracts lacking NTHL1 (NTHL1-/-) suggest that NTHL1 is the
primary DNA glycosylase for Tg removal, and the sole DNA glycosylase for Tg removal
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in mitochondrial liver cells (Ocampo, Chaung et al. 2002, Karahalil, de Souza-Pinto et al.
2003). From bacteria to mammals Nth is thus critical to efficient Tg removal in the
genome.

1.6.4 Human NTHL1

Human endonuclease III-like (hNTHL1) DNA glycosylase is a housekeeping
gene, with increased expression during S phase (Luna, Bjoras et al. 2000). The activity of
NTHL1 differs from bacterial Nth in multiple ways, and these differences are currently
attributed to the extended N-terminus in eukaryotes. Eukaryotic NTHL1, mainly
mammalian, have extended N-termini that are predicted to be disordered by disorder
prediction programs such as PONDR-FIT (Xue, Dunbrack et al. 2010). hNTHL1
sequesters the DNA and sits on the lesion for a longer period of time than EcoNth (Liu
and Roy 2002). The off rate can be increased with the truncation of the N-terminal
extension, the addition of APE1, YBOX1, XPG, or another unidentified factor
(Klungland, Hoss et al. 1999, Memisoglu and Samson 2000, Marenstein, Ocampo et al.
2001, Liu and Roy 2002, Marenstein, Chan et al. 2003, Maher, Marsden et al. 2017). This
finding suggests that hNTHL1 has evolved an extended N-terminus to remain bound to
DNA, protecting the fragile abasic site while waiting for APE1. Furthermore, hNTHL1
exhibits a sigmoidal activity suggesting a dimeric state, which can be seen via
crosslinking on a denaturing gel. The cooperativity and dimer formation decrease as the
N-terminal extension is truncated (Liu, Choudhury et al. 2003).
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Fitting with the BER coordination model, APE1 stimulates NTHL1 product
formation and release on naked DNA in multiple-turnover conditions (Marenstein, Chan
et al. 2003). APE1 is thought to reduce the affinity of NTHL1 for the AP site due to steric
changes of the DNA because a direct APE1-NTHL1 interaction has yet to be observed
(Mol, Izumi et al. 2000, Kladova, Bazlekowa-Karaban et al. 2018). This would bypass
the β-elimination reaction of NTHL1 allowing APE1 to reduce the AP site (Marenstein,
Chan et al. 2003). These results on naked DNA suggested that NTHL1 may act more as a
monofunctional glycosylase than a bifunctional glycosylase. Recent work by the
Pederson group has shown that APE1 does not increase NTHL1 turnover on nucleosomes
under multiple turnover conditions, and that NTHL1 lyase activity contributes to the
processing of AP sites (Maher, Wallace et al. 2019).

1.6.5 NTHL1 Mouse Models
The early Nthl1-/- mice showed no phenotypic defect (Ocampo, Chaung et al.
2002, Takao, Kanno et al. 2002, Takao, Kanno et al. 2002). Further examination of
mouse Nthl1-/- extracts even showed cleavage of Tg, highlighting the redundancy of the
BER pathway for oxidized pyrimidines (Ocampo, Chaung et al. 2002). However, Nthl1
was found to be the only DNA glycosylase able to excise Tg from mouse liver
mitochondrial extracts (Karahalil, de Souza-Pinto et al. 2003). This is in conflict with the
findings of Takao et al., who purified mouse mitochondrial extracts and found that Fpg
was present and able to excise Tg (Takao, Kanno et al. 2002). The stereoisomers of Tg
are a potential explanation for these conflicting phenotypes, but Nthl1 has an integral role
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in Tg removal from the mitochondrial genome. Vallabhaneni et al. observed defects at
telomeres in Nthl1-/- mouse embryonic fibroblast (MEF) cells. There was an
accumulation of Nthl1 substrates and slower repair at telomeric DNA when compared to
non-telomeric DNA. Nthl1 knockout culture mouse bone marrow cells also have
shortening of the telomeres, increased recombination at telomeres, DNA damage foci and
fragile telomere sites (Vallabhaneni, O'Callaghan et al. 2013). This study suggests that
Nthl1 plays an important role in oxidized pyrimidine removal at telomeres, elucidating a
role of Nthl1 in cancer and aging. The Nthl1-/ - Nei1-/- double knockout mice developed
pulmonary and hepatic tumors after two years, highlighting the carcinogenicity of DNA
lesions other than 8-oxoG and BER defects driving carcinogenesis (Chan, OcampoHafalla et al. 2009).

1.6.6 Implication in Human Disease

The BER pathway has been implicated in the progression of cancers, with the idea
that mutations in the BER enzymes reduce the effectiveness of the enzyme to repair
damaged DNA, thus propagating mutations throughout the genome (Wallace, Murphy et
al. 2012). NTHL1 has been directly linked to familial inheritance colorectal cancer
(CRC), and adenomatous polyposis by whole exome sequencing (Weren, Ligtenberg et
al. 2015, Valle, de Voer et al. 2019). Multiple studies have found that NTHL1-associated
polyposis (NAP) has biallelic germline nonsense NTHL1 mutations that render the DNA
glycosylase inactive. Biallelic mutations have been found in 14 different tumor types,
notably colorectal, breast and endometrial cancers. (Rivera, Castellsague et al. 2015,
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Weren, Ligtenberg et al. 2015, Belhadj, Mur et al. 2017, Broderick, Dobbins et al. 2017,
Fostira, Kontopodis et al. 2018, Grolleman, de Voer et al. 2019, Groves, Gleeson et al.
2019) Weren et al. estimate the prevalence of NAP at 1:114,770 in the European decent
(Weren, Ligtenberg et al. 2018). More recently, the Valle group reported a 1.9%
prevalence of NTHL1 biallelic mutations in polyposis patients and they typically present
as adenomas potentially with CRC, serrated polyps, and multi-tumor phenotypes
(Belhadj, Quintana et al. 2019, Terradas, Munoz-Torres et al. 2019). The NAP tumors
revealed a strong C>T transition pattern (Weren, Ligtenberg et al. 2015). Drost et al.
identified NTHL1 deficiency as the root of mutation signature 30, using human intestinal
organoids (Drost, van Boxtel et al. 2017). Signature 30 is a hallmark of breast cancers,
and retrospectively the breast tumor in which signature 30 was identified was determined
to be NTHL1 deficient (Nik-Zainal, Davies et al. 2016). Grolleman et al. has identified
four more breast tumors where signature 30 accounts for 80% of the mutations,
suggesting that NTHL1 deficiency has driven the formation of these tumors (Grolleman,
de Voer et al. 2019). Transcriptome sequencing of a pancreatic neuroendocrine tumor
revealed signature 30, and NTHL1 loss, implicating NTHL1 loss as a driver of another
tumor type (Wong, Yang et al. 2018). Due to improved DNA sequencing techniques
there has been a recent explosion of scientific papers suggesting that NTHL1 loss is a
driver of adenomas and other tumor types.
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1.7 Repair of Transfer RNA

As we discussed in the previous sections there are multiple pathways in place to
repair DNA. As it turns out, some organisms have evolved mechanisms to repair RNA. In
this section we will focus on the repair of transfer RNA (tRNA). tRNA bridges the gap
during translation of mRNA into protein, by carrying the cognate amino acid to the
ribosome for nascent peptide synthesis. Correct charging of the tRNA by its aminoacyltRNA synthetase and recognition by the ribosome is critical (Lant, Berg et al. 2019). In
all kingdoms of life, tRNAs adopt a cloverleaf structure, which folds into an L – shape
exposing a 3’ acceptor stem that is charged with an amino acid on one end, and the
anticodon recognized by mRNA on the other (Figure 6). Aminoacyl-tRNA synthetases
can recognize their specific tRNA by the 3’ acceptor stem where the amino acid residue
is attached, the anticodon consisting of three ribonucleotides, and/or the 5’ end (Voet,
Voet et al. 2013). Extensive modifications and editing of tRNAs occur during maturation.
Differentiating between editing and modifying can be somewhat ambiguous. Here we
will classify the process as editing if the canonical RNA bases (adenine, cytosine,
guanine, and uracil) are involved, such as during excision of the 3’-trailer and 5’-leader
ends, splicing of introns, and addition of the CCA sequence to the 3’ acceptor stem. And
tRNA modifications as incorporation of non-canonical bases, of which more than 100
substitutions have been identified (Jackman and Alfonzo 2013, Betat, Long et al. 2014).

Recent studies have directly linked tRNA mutations to disease in mice and
humans, including neurodegeneration and cancer (Ishimura, Nagy et al. 2014,
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Schoenmakers, Carlson et al. 2016, Kapur and Ackerman 2018, Santos, Pereira et al.
2018). A SNP in a tRNA gene can lead to mistranslation or stalling of the ribosome
(Lant, Berg et al. 2019). Mutations in tRNA can lead to expression level differences, misacylation, or misprocessing events, resulting in mistranslation of the mRNA, frameshifts
in the protein, ribosome stalling, or increased translation rates. Similarly, if translation
rates are altered, the concentration of a protein may change with potentially serious side
effects depending upon function (Lant, Berg et al. 2019). Hence, it is important that
tRNAs are edited and modified accurately to ensure homeostasis of the proteome.

1.7.1 Editing of tRNA

Maturation of tRNA involves extensive editing, either substitutions, insertions
or deletions of the canonical RNA bases: A, C, G, or U (Gray 2012). The immature or
precursor tRNA contains a 5’-leader and 3’-trailer sequence. 3’- tRNA editing occurs in
many metazoan mitochondria, and even in human mitochondria. The tRNA genes have
overlapping regions, such that the 3’ acceptor stem will contain mismatches. Templatedependent and independent mechanisms have been identified in 3’tRNA repair (Betat,
Long et al. 2014). Ribonuclease P (RNase P) predominantly cleaves the 5’-leader
sequence between the N and N+1 nucleotides, although miscleavage between N+1 and
N+2 has been observed, generating a presumably nonfunctional tRNA (Walker and
Engelke 2006, Chen, Singh et al. 2012).
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1.7.2 tRNAHis guanylyltransferase - like protein

It is believed that most of the damaged RNA is degraded by the cell, as RNA is
intrinsically less robust than DNA (Edenberg, Downey et al. 2014). Even so, there are
known RNA damage repair proteins. Repair of mismatches in the 5’ end of some tRNAs
by yet to be identified nuclease(s) and reverse polymerization with Watson-Crick base
pairing was observed in metazoans and archaea (Price and Gray 1999, Rao, Maris et al.
2011, Hyde, Rao et al. 2013). Reverse polymerization is a three-step mechanism
involving: 1) adenylation (or guanylation) of the 5’ end, 2) nucleotidyl transfer, and 3)
release of pyrophosphate group (Figure 7). The essential enzyme in S. cerevisiae,
tRNAHis guanylyl transferase 1 (THG1), was the first enzyme identified that was able to
perform 3’5’ polymerization. THG1 adds G at the N-1 position of tRNAHis, a
modification which is necessary for tRNAHis maturation (Gu, Jackman et al. 2003). This
reaction is not templated. The THG1 enzymes do not have activity on truncated tRNAs,
suggesting that they are not involved in tRNA mismatch repair (Jackman and Phizicky
2006).

The THG1-like proteins (TLPs) were subsequently identified in archaea and
bacteria. TLPs catalyze reverse polymerization of tRNAs through Watson-Crick base
pairs and have been shown to extend the 5’ end of truncated tRNAs, implicating TLP in
the repair of mismatches and truncations (Abad, Rao et al. 2010, Rao, Maris et al. 2011,
Long, Abad et al. 2016). Intriguingly, TLPs can repair any tRNA as they do not bind the
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anticodon and therefore are nonspecific (Abad, Long et al. 2011, Kimura, Suzuki et al.
2016). It has also been suggested that some TLPS may potentially repair/edit small noncoding RNAs (Chen, Jayasinghe et al. 2019, Dodbele, Moreland et al. 2019). In this
dissertation we identified a novel molecular intermediate between guanylation and
nucleotidyl transfer steps in the archaea Methanobrevibacter smithii TLP.
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1.8 Figures

Figure 1- 1: DNA Lesions
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The DNA bases and lesions mentioned in the text are depicted and grouped.
Outlined in blue are the four main DNA bases, adenine, guanine, cytosine, and thymine.
Uracil is outlined in navy, as it is a DNA lesion. 5mC and its oxidation products, 5hmC,
5fC, and 5-caC are outlined in green, and the other methylated bases, N7-methylguanine,
O6-methylguanine, O4-methylthymine, and O4-ethylthymine are outlined in forest green.
The deaminated purines, hypoxanthine and xanthine, are outlined in magenta, as
deaminated cytosine is uracil and deaminated 5mC is thymine. An AP site is shown in
purple. Tg and 8-oxoG are boxed in red. This list of damaged bases is not exhaustive but
rather serves as an illustration of the various types of damage presented in this
dissertation.
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Figure 1- 2: Overview of DNA Repair
An overview of the DNA repair pathways. DNA damaging events are shown above the
DNA helix, which has depictions of types of DNA lesions that can occur. The four major
DNA repair pathways, BER, NER, MMR, and DSB repair are shown below the helix
with the lesions that are recognized.
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Figure 1- 3: Short Patch Base Excision Repair Pathway
The concerted steps of the short patch BER pathway are drawn. The DNA lesion is
depicted by a red square, and the colored circles are undamaged DNA bases. The first
step of the BER pathway is recognition and removal of the lesion by DNA glycosylases,
which can be divided into two groups, monofunctional and bifunctional. The second
enzyme, either APE1 or PNK, cleans up the DNA ends creating a substrate for Polβ. Polβ
inserts the correct opposite base and XRCC1/LIG IIIα seals the nick.
Figure inspired by Wallace et al., 2013
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Figure 1- 4: DNA Glycosylase Super Families
The glycosylases can be divided into 4 super families: Udg, HhH, H2TH, and
AAG. The basic folds of the DNA glycosylase families are pictured, with the DNA
glycosylases in cartoon representation colored from blue to red (N-terminus to Cterminus). The DNA backbone is orange, and the bases are magenta. The Udg family,
represented here by human UDG (PDB ID code: 2SSP), has an α- and β-fold, with the
DNA binding in the positively charged cleft between the folds (Parikh, Mol et al. 1998).
The HhH/Nth family, depicted by GstNth (PDB ID code: 1ORN), has two domains
(Fromme and Verdine 2003). The six-helical bundle domain contains the HhH DNA
binding motif (grey), and the [4Fe4S] domain. The DNA binds in the cleft formed
between the two domains. The H2TH/Nei family, shown by human NEIL1 (PDB ID
code: 5ITR), has two domains with a H2TH (grey) and Zinc or Zinc-less finger (grey)
DNA binding domains (Zhu, Lu et al. 2016). Lastly, the AAG family has a single α/β
domain, show here by human AAG (PDB ID code: 1BNK)(Lau, Scharer et al. 1998).
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Figure 1- 5: Domain orientations of DNA glycosylases
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A slew of liganded and unliganded DNA glycosylase crystal structures have been solved.
Two DNA glycosylases have shown gross interdomain movements, EcoNei and UDG,
shown in the left panel. EcoNei exhibits an interdomain conformation with the apo
structure (green, 1Q39) rotating and closing 50o to form the closed structure (magenta,
1K3W) (Zharkov, Golan et al. 2002, Golan, Zharkov et al. 2005). Human UDG has a
more modest 10o “pinching” in of the open, unbound conformation (green, 1AKZ)
meeting the closed, bound conformation (magenta, 2SSP) (Parikh, Mol et al. 1998). The
right half of the figure shows the multitude of DNA glycosylases that do not appear to
have interdomain changes. The H2TH family is represented by human NEIL1 apo
(1TDH, orange) and DNA bound (5ITR, lime), and Mimi virus Nei1 apo (3A42, orange)
and (3A46, lime) (Doublie, Bandaru et al. 2004, Imamura, Wallace et al. 2009, Zhu, Lu
et al. 2016). The HhH family is represented by Clostridium acetobutylicum Ogg1 (3F0Z,
orange) and (3I0X, lime) (Baba, Maita et al. 2005, Faucher, Robey-Bond et al. 2009,
Pidugu, Flowers et al. 2016). The UDG family is depicted by human TDG unbound
(1WYW, orange) and bound (5T2W, lime) and Arabidopsis thaliana Fpg apo (3TWL,
orange) and DNA bound (3TWM, lime) (Baba, Maita et al. 2005, Duclos, Aller et al.
2012, Pidugu, Flowers et al. 2016). Some of these structures have slight movement
between helices but the interdomain orientations are nearly identical.
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Figure 1- 6: Basic structure of tRNA
All tRNA adopt a cloverleaf structure. The 3’ acceptor stem is where the amino
acid attaches. The anticodon is read by the ribosome to attach the proper amino acid to
the growing protein chain.
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Figure 1- 7: Reverse polymerization mechanism
The reverse polymerase reaction occurs first with adenylation (or guanylation)
of the 5’ end of the tRNA. The incoming nucleotide, guanine, attacks the 5’ phosphate of
the tRNA, with AMP as the leaving group. The last step is hydrolysis of the triphosphate,
leaving a 5’monophosphate, and a pyrophosphate leaving group.
Figure inspired by Hyde, et al., 2010
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CHAPTER II: HUMAN NTHL1 UNDERGOES A NOVEL
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Brittany L. Carroll1, Karl E. Zahn2, and Sylvie Doublié1
1

Department of Microbiology and Molecular Genetics, University of Vermont, 95
Carrigan Drive, Burlington, VT 05405, USA
2

Howard Hughes Medical Institute, New Haven, CT

2.1 Abstract

Base excision repair (BER) is the primary pathway for removing and replacing
oxidized bases. The BER pathway is initiated when a DNA glycosylase binds an oxidized
base and cleaves the N-glycosidic bond between the base and the deoxyribose moiety.
The DNA glycosylase, Endonuclease-like III (Nth), recognizes and excises oxidized
pyrimidines. To date, there is no crystal structure of any eukaryotic Nth-like (hNTHL1)
enzyme. The bacterial homologs, of which there are several crystal structures, exhibit a
bilobal protein fold with six helical barrel and [4Fe4S] cluster domains connected by two
flexible linkers. Differences in regulation and biochemical function suggest a structural
divergence between prokaryotic Nth and eukaryotic hNTHL1 enzymes. We solved the
first crystal structure of a catalytically active N-terminal deletion construct of human
hNTHL1 (hNTHL1Δ63), which revealed a novel open conformation not observed in its
prokaryotic orthologs. The novelty of this configuration, in which the glycosylase domain
has tipped away from the [4Fe4S] binding site, suggests a conformational change upon
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DNA binding unique to the human enzyme. We have attributed the flexibility of
hNTHL1 to an extended linker that extends from the [4Fe4S] domain to the six- helical
barrel domain. Swapping of the human linker for the shorter E. coli linker led to
decreased binding affinity of lesion-containing DNA. Furthermore, characterization of
hNTHL1 G286S, a germline variant found in a patient with Familial adenomatous
polyposis 3, shows impaired glycosylase and β-elimination function with retained
product release.

2.2 Introduction

The base excision repair (BER) pathway is the cells primary way of coping with
the 30,000 daily oxidative assaults, which can be mutagenic or stall replicative DNA
polymerases if left unrepaired (Lindahl 1993, De Bont and van Larebeke 2004, Edenberg,
Downey et al. 2014, Wallace 2014). BER is an enzymatic pathway which recognizes and
repairs oxidative and small, non-bulky lesions in a stepwise manner (Wallace 2014).
Glycosylases are the first enzymes in the BER pathway, and are responsible for scanning
the genome, recognizing, and excising the DNA lesion (Wallace 2013). Endonuclease IIIlike 1 (hNTHL1), one of 11 DNA glycosylases encoded in the human genome, is a
bifunctional glycosylase, meaning that it has both glycosidic and lytic activity on the
DNA backbone (Aspinwall, Rothwell et al. 1997).

The Escherichia coli Nth (EcoNth) crystal structure revealed that the enzyme is
comprised of two globular domains, an N-terminal six-helix barrel domain containing a
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hairpin-helix-hairpin (HhH) DNA binding motif and a C-terminal domain containing an
iron-sulfur [4Fe4S] cluster (Kuo, McRee et al. 1992, Kuo, McRee et al. 1992,
Cunningham, Ahern et al. 1994, Thayer, Ahern et al. 1995). The Geobacillus
stearothermophillus Nth (GstNth) with DNA crystal structure showed that both domains
interact with the DNA, and binding occurs in the cleft between the two domains (Fromme
and Verdine 2003). The extremophile Deinococcus radiodurans has three Nth1
homologs, two of which have been crystallized (Sarre, Okvist et al. 2015). The EcoNth
and DraNth were crystallized unliganded, whereas GstNth was crystallized bound to
DNA. Comparison of these structures show that there is no interdomain conformational
changes of Nth upon binding DNA.

In this study, we aimed to elucidate the structural differences between bacterial
and human Nth. We have solved the first crystal structure of human hNTHL1, where we
observed a novel open conformation, indicating that a large-scale conformational change
must occur during catalysis. We show that the length of the linker between the two
domains is necessary for the open conformation.

hNTHL1 has recently been identified as a predisposing gene for polyposis and
colorectal cancer, called hNTHL1-associated polyposis (NAP), and most recently has
also been implicated in high-risk breast cancer (Rivera, Castellsague et al. 2015, Weren,
Ligtenberg et al. 2015, Belhadj, Mur et al. 2017, Broderick, Dobbins et al. 2017, Fostira,
Kontopodis et al. 2018, Grolleman, de Voer et al. 2019, Groves, Gleeson et al. 2019).
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NAP has been observed in patients with homozygous nonsense hNTHL1 mutations, and
the predisposition of heterozygous patients has yet to be determined. Although single
nucleotide polymorphisms (SNPs) have yet to be identified in NAP, hNTHL1 was shown
that to have the ability to drive cancer progression. Although the germline SNP variant
hNTHL1 G286S has not been directly implicated in NAP, it was been identified in a
familial adenomatous polyposis patient and is of particular interest because of its close
proximity to the [4Fe4S] cluster (Forbes, Beare et al. 2015). We show that the hNTHL1
G286S variant is much slower at the chemistry step in the glycolytic cleavage compared
to hNTHL1, suggesting that tumors with hNTHL1 G286S have impaired oxidized
pyrimidine removal.

2.2 Materials and Methods

2.2.1 Expression of hNTHL1

The following protein constructs, hNTHL1, hNTHL1∆63, hNTHL1 G286S,
hNTHL1∆63 G286S and hNTHL1∆63-linker, were overexpressed in the pET30a vector
in E. coli Rosetta2 DE3 pLysS cells (Novagen), using autoinduction as previously
described (Studier 2005). Briefly, cells were grown in Terrific Broth media supplemented
with 5052 sugar mix, ampicillin, and chloramphenicol, at 20oC for 60 hours. The cells
were lysed by sonification at 4oC in 500mM NaCl, 20 mM Tris pH8, 20 mM imidazole,
10% glycerol, 3 mM β-mercaptoethanol, 1mM PMSF. Cell lysate was cleared at
23,000xg for one hour. The cleared cell lysate was passed over a Ni-NTA resin using
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gravity flow. The protein was eluted using 5 column volumes (CV) of elution buffer,
100mM NaCl, 20 mM Tris-HCl pH 8, 250 mM imidazole, 10% glycerol, 3 mM βmercaptoethanol. The protein was further purified over a heparin column (GE
Healthcare), in 100 mM NaCl, 20 mM Tris-HCl pH 8, 20 mM imidazole, 10% glycerol,
1mM TCEP with a 20 CV salt gradient (0.1 – 5M NaCl). The protein typically elutes
around 300 mM NaCl. A Superdex 75 gel filtration column (GE Healthcare) was the final
column with a buffer composed of 100mM NaCl, 20 mM Tris-HCl pH8, 20 mM
imidazole, 10% glycerol, 1mM TCEP. Proteins were concentrated to ~8 mg/ml
(Amicon), flash frozen in LN2, and stored at -80oC.

2.2.2 Selenomethionyl-protein purification

The pET30a hNTHL1∆63 construct was overexpressed in E. coli Rosetta2 DE3
pLysS cells (Novagen), in minimal medium containing selenomethionine at 125 μg/mL,
as described in (Doublie 2007). Briefly, the cells were grown to an optical density of 0.6
at 37oC, and then induced with 500 mM IPTG at 25oC for 4 hours. The protein was
purified using the procedure described above.

2.2.3 Purification of DNA substrates

The following DNA substrates were chemically synthesized (Midland): an
11mer damaged strand 5’ TGTCCAXGTCT, where X is the non-hydrolysable abasic site
analog, tetrahydrofuran (THF)and its 11mer complement 5’ AAGACGTGGAC . For the
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activity assays 35mer oligonucleotides were used: damaged strand 5′
TGTCAATAGCAAG(X)GGAGAAGTCAATCGTGAGTCT 3′ and complementary
strand 5′ AGACTCACGATTGACTTCTCC(G/A)CTTGCTATTGACA 3′, where X is
the DNA lesion, either THF, Tg, DHU, or U. (G/A) represents the opposite base. The
DNA oligos were resuspended in 200 μl of TE buffer and 800 μl of formamide. The
samples were PAGE purified over a 30% acrylamide urea (National Diagnostics) gel, run
at 55 Watts for 6 hours. The bands were cut out of the gel, crushed, and soaked overnight
in 50 mM NaCl and 50 mM Tris-HCl pH 8. The gel pieces were filtered out and the
solution was run over a SepPak C18 column (Waters). The oligonucleotides were eluted
in 75% acetonitrile. The acetonitrile was evaporated using a Speedvac, and the
oligonucleotides were resuspended in annealing buffer (50 mM NaCl, 50 mM Tris-HCl
pH 8). The oligonucleotides were annealed at an equimolar ratio using a hot water bath
at 95oC and allowed to cool to room temperature slowly in the water.

2.2.4 Crystallization of hNTHL1
Both hNTHLΔ63 and hNTHLΔ63 SeMet crystals were grown using the hanging
drop method with a final concentration of 3.5 mg/ml, incubated at 18oC, and streak
seeded 18 hours later. The reservoir solution ranged from 0.5-2% Polyethylene glycol
5,000 monomethyl ether (PEG 5K MME, Hampton Research), 75 – 100 mM NaCl, and
100 mM tricine pH 8.5. The condition was optimized from the Index screen HT
(Hampton Research) condition F12, 0.2M NaCl, 0.1M HEPES pH 7.5, 25% Peg 3350.
Long needle-like crystals were cut to ~600 μM and soaked for 30 minutes in a 1:1
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solution of mother liquor and a cryoprotecting solution of 10% (w/v) PEG 5K MME, 10
mM NaCl, 50% (w/v)glycerol, 50 mM Tricine pH 8.5.

The hNTHL1Δ63 chimera crystals were grown using the hanging drop method
with a final concentration of 3 mg/ml, incubated at 18oC, and streak seeded 3 hours later.
The reservoir solution ranged from 0.5-2% Polyethylene glycol 6,000 (PEG 6K,
Hampton Research), 55 mM NaCl, and 100 mM Tricine pH 8.3. Needle-like crystals
grew to approximately 400 x 70 x 70 μm3 over 5 days. Crystals were soaked for 30
minutes in a 1:1 solution of mother liquor and a cryoprotecting solution composed of
10% (w/v) PEG 6K, 10 mM NaCl, 50% (w/v)glycerol, 50 mM Tricine pH 8.3.

hNTHL1Δ63 G286S crystals were grown using the hanging drop method with a
final concentration of 4.5 mg/ml, incubated at 18oC, and streak seeded 3 hours later. The
reservoir solution ranged from 1-4% PEG 5K MME (Hampton Research), 20-30 mM
NaCl, and 100 mM Tricine pH 8.3. Needle-like crystals were soaked for 30 minutes in a
1:1 solution of mother liquor and a cryoprotecting solution of 10% (w/v) PEG 5K MME,
10 mM NaCl, 50% (w/v) glycerol, 50 mM Tricine pH 8.3.

hNTHL1Δ63 and DNA were incubated in a 1:1.2 molar ratio for 30 minutes on
ice prior to setting hanging drops. The drops were set at 8 mg/ml of hNTHL1Δ63.
Orthorhombic crystals were obtained in 175 mM NaCl, 50 mM MgSO4, 12% PEG 3350,
100 mM HEPES pH 7.5. Crystals appeared after 1 year. Monoclinic centered crystals
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were grown in 25% PEG 3350, 100 mM NaCl, 50 mM MgSO4, 100 mM HEPES pH 7.5,
2 mM TCEP. Crystals appeared after 6 months. Both crystal forms were cryo-cooled in
20% PEG 3350, 50 mM MgSO4, 100 mM NaCl, 100 mM HEPES pH 7.5, 14% ethylene
glycol.

2.2.5 Data collection and processing of crystals
hNTHL1Δ63 crystals diffracted to 2.3Å at the APS synchrotron (beamline 23ID-B). Data were collected using the 20-micron beam tuned to 12 kEV. A complete
dataset was obtained by using the vector function along the length of the crystal. The
hexagonal (P63) crystals were integrated, scaled, and truncated using iMOSFLM,
AIMLESS/POINTLESS, and CTRUNCATE (Evans 2006, Battye, Kontogiannis et al.
2011, Evans 2011, Winn, Ballard et al. 2011, Evans and Murshudov 2013).

hNTHL1Δ63 SeMet crystals were collected at the APS synchrotron (beamline
23-ID-B) at a wavelength of 0.9795Å. The crystals diffracted past 3.4 Å. Data were
collected using a 20-micron beam and the vector function described above. The SeMet
crystals were hexagonal (P63) and were processed using HKL2000.

hNTHL1Δ63 chimera crystals diffracted to 2.1Å at the APS synchrotron
(beamline 23-ID-X) at 12 kEV. The vector function was again employed in order to
obtain a complete dataset. The hNTHL1Δ63 chimera crystallized in the orthorhombic
space group, P212121, and were integrated, scaled, and truncated using iMOSFLM,
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AIMLESS/POINTLESS, and CTRUNCATE (Evans 2006, Battye, Kontogiannis et al.
2011, Evans 2011, Winn, Ballard et al. 2011, Evans and Murshudov 2013).

The orthorhombic DNA crystals were collected at the APS synchrotron on
beamline 23-IDB at 12 kEV. Two datasets were collected on two separate crystals,
approximately, 25 x 25 x 25 μm3, which diffracted X-rays to 2.5 Å and 2.0 Å. The data
were processed using MOSFLM, HKL2000, DIALS, PROTEUM3 and XDS
(Otwinowski and Minor 1997, Kabsch 2010, Battye, Kontogiannis et al. 2011, Winter,
Waterman et al. 2018). Two monoclinic datasets were collected at the APS synchrotron
on beamline 23-IDB, one at 12 kEV and the other at 7.9 kEV, from a single crystal,
approximately 20 x 30 x 60 μm3. The data were processed using MOSFLM, HKL2000,
DIALS, PROTEUM3 and XDS (Otwinowski and Minor 1997, Kabsch 2010, Battye,
Kontogiannis et al. 2011, Winter, Waterman et al. 2018). The data were phased
experimentally using SHARP and the sites were verified manually by calculating
anomalous difference Patterson map (Bricogne, Vonrhein et al. 2003, Winn, Ballard et al.
2011).

2.2.6 Structure Solution and Refinement

hNTHL1Δ63 crystals were experimentally phased by Single-wavelength
Anomalous Dispersion (SAD) methods. The selenium sites were identified by PHENIX
autoSOL (Adams, Afonine et al. 2010, Terwilliger, Read et al. 2013). The hNTHL1Δ63
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chimera dataset was solved by molecular replacement using hNTHL1Δ63 as a search
model. The two domains were separated and searched for individually using PHENIX
autoMR (McCoy, Grosse-Kunstleve et al. 2007, Adams, Afonine et al. 2010). All forms
of the hNTHL1Δ63 unliganded crystals were refined using PHENIX and
Translation/Libration/Screw (TLS) model (Afonine, Grosse-Kunstleve et al. 2009,
Adams, Afonine et al. 2010, Afonine, Grosse-Kunstleve et al. 2012, Headd, Echols et al.
2012, Afonine, Grosse-Kunstleve et al. 2013, Urzhumtsev, Afonine et al. 2013).

2.2.7 Radiolabeling DNA

DNA oligonucleotides for single-turnover or multiple-turnover experiments
were labeled 10% hot and for EMSAs were labeled 100% hot. The damage-containing
oligonucleotide was incubated with P32 γ-ATP and polynucleotide kinase for 30 minutes.
The reaction was quenched with 25 mM EDTA and heat inactivated for 1 min at 95oC.
The DNA was cleaned up by either ethanol precipitation for the 10% hot oligonucleotide,
or a G-50 Probequant desalting column (GE Healthcare) for the 100% hot labelling. The
damaged oligo and complementary strand were brought up to a final concentration of
250nM in a DNA annealing buffer (10 mM Tris-HCl pH 8 and 50 mM NaCl) and
annealed in 1:1 ratio in a 95oC water bath and allowed to cool slowly to room
temperature.
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2.2.8 Single Turnover Kinetics Experiments

To perform the single-turnover kinetics experiments 100 nM of hNTHL1 or
hNTHL1 G286S were added to a solution of 20 nM of radiolabeled DNA containing
either DHU, Tg, or AP site, 2 mg/ml BSA (New England Biolabs), 10 mM Tris-HCl
pH 8, 75 mM NaCl, 1 mM DTT at 37oC. Time points were taken at 0, 0.25, 0.5, 1, 2, 3, 4,
5, 8, 10, 20, 30, 45, 60 minutes and quenched in equal volume of formamide stopping dye
(95% formamide, bromophenol blue, xylene) or 0.1M NaOH and boiled for 5 min before
adding equal volume formamide stopping dye. Samples were loaded onto a 12%
sequencing gel and run at 55 watts for 1 hour. The gels were dried and exposed on
phosphorescence screens (Kodak) and scanned on a BioRad Plus phosphor imager.
Phosphorescence was quantified using Quantity One. The data were fit to the equation
Y=Y0 + (Plateau-Y0)*(1-exp(-K*x)) using Graph Pad Prism (GraphPad Prism version
8.1.2 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com).

The single-turnover assays for hNTHL1Δ63 or hNTHL1Δ63 chimera were
performed as above, except that 25 nM of Tg:A DNA oligo was used, and the reactions
were quenched with either 100 mM NaOH and boiled, or formamide stopping dye. The
gels were scanned using a STORM imager (GMI).
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2.2.9 Multiple Turnover Kinetics Experiments

To perform the multiple turnover kinetics experiments, 20 nM of hNTHL1 or
hNTHL1 G286S were added to a solution of 20 nM of radiolabeled DNA containing
either DHU, Tg, or AP site, 2 mg/ml BSA (NEB), 10 mM Tris pH8, 75 mM NaCl, 1 mM
DTT at 37oC. Time points were taken at 0, 0.25, 0.5, 1, 2, 3, 4, 5, 8, 10, 20, 30, 45, 60
minutes and quenched in equal volume of formamide stopping dye (95% formamide,
bromophenol blue, xylene). Samples were loaded onto a 12% sequencing gel and run at
55 watts for 1 hour. The gels were dried using a heater and vacuum pump and exposed on
phosphor screens (Kodak) and scanned on a BioRad Plus phosphor imager.
Phosphorescence was quantified using Quantity One. The data were fit to the equation
Y=Y0 + (Plateau-Y0)*(1-exp(-K*x)) using Graph Pad Prism (GraphPad Prism version
8.1.2 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com).

2.2.10 Electrophoretic Mobility Shift Assay

Electrophoretic Mobility Shift Assays (EMSAs) were performed with varying
concentrations of hNTHL1Δ63 or hNTHL1Δ63 chimera from 0-1750 pM, and 50 pM of
radiolabeled THF: G DNA. The reactions were incubated in the same buffer listed above
with 10% glycerol for 30 minutes at room temperature. The samples were run on a 6%
non-denaturing polyacrylamide gel (AMERIBIO) at 4oC for 2 hours at 150 Watts. The
gels were dried using a heater and vacuum pump and exposed overnight on phosphor
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screens. The gels were scanned using a STORM imager (GMI) and quantified in Quantity
One (BioRad).

2.3 Results
2.3.1 Structural description of human hNTHL1

We present the first crystal structure of any eukaryotic Nth enzyme. We solved
the crystal structure of hNTHL1 using SAD to 2.3Å with an R-work/R-free of
19.90%/23.08% (Table 1). Some NTHL1 glycosylases, mainly mammalian, harbor
disordered N-terminal extensions, including human hNTHL1. The N-terminal extension
encompasses the nuclear and mitochondrial localization sequences, and has been
implicated in hNTHL1 dimerization, DNA binding, and protein-protein interactions
(Marenstein, Ocampo et al. 2001, Liu and Roy 2002, Liu, Choudhury et al. 2003). Our
crystallization construct, hNTHL1∆63, lacking the first 63 residues, was selected for
crystallization because the disordered region was hindering crystal formation.
Furthermore, the Roy group had previously characterized this construct, where it was
shown to be active (Liu and Roy 2002, Liu, Choudhury et al. 2003). The crystallized
construct contains 249 amino acids, forming a total of 12 alpha helices. Like its bacterial
homologs, hNTHL1 comprises two globular domains: a six-helical barrel domain which
contains a helix-hairpin-helix (HhH) DNA-binding motif, and a C-terminal domain
containing a [4Fe- 4S] cluster domain (Figure 1)(Kuo, McRee et al. 1992, Kuo, McRee et
al. 1992, Cunningham, Ahern et al. 1994, Thayer, Ahern et al. 1995, Fromme and
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Verdine 2003, Sarre, Stelter et al. 2019). Surprisingly, our hNTHL1∆63 model reveals a
novel open conformation (Figure 2), which is not observed in any of the bacterial Nthfamily glycosylases previously crystallized without DNA, EcoNth (PDB ID 2ABK,
RMSD 7.38Å) and DraNth (PDB IDs 4UNF & 4UOB, RMSD 8.37 Å & 10.30 Å,
respectively). All bacterial unliganded Nth structures exhibit a similar domain orientation
compared to the DNA-bound GstNth (PDB ID 1ORN). The open conformation of
hNTHL1Δ63 was confirmed by anomalous peaks in the selenomethionine dataset,
pinpointing the location of the methionine residues. (Figure 1C).

2.3.2 The flexible linker is necessary for open state
In the open state, hNTHL1Δ63 is predicted to be unable to perform catalysis
because the strictly conserved catalytic residues, lysine 220 and aspartate 239, are 23 Å
apart (Figure 2). Therefore, hNTHL1 must undergo a conformational change (Aspinwall,
Rothwell et al. 1997, Saito, Uraki et al. 1997, Liu and Roy 2001, Galick, Kathe et al.
2013, Robey-Bond, Benson et al. 2017). EcoNei, a DNA glycosylase from the Fpg/Nei
family, exhibits a similar conformational change between the unliganded and DNAbound forms. EcoNei, like hNTHL1, also harbors a flexible hinge region (Golan,
Zharkov et al. 2005). Based upon this precedent, we investigated the role of linkers in
hNTHL1.

Both the N- and C- termini of hNTHL1 reside in the [4Fe-4S] cluster domain;
thus, the two domains are connected by two linkers. The first linker region in hNTHL1
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comprises a 10-amino acid insertion compared to bacterial Nth sequences: 6 residues are
located in the loop and 4 residues extend helix C (Figure 3, magenta). To test whether the
open conformation in hNTHL1 was due to increased flexibility of the extended linker, we
engineered a chimera of hNTHL1∆63 and EcoNth, by replacing the human linker with
the shorter EcoNth linker (hNTHL1∆63 chimera, Figure 3, Table 2).

We solved the crystal structure of hNTHL1∆63 chimera to 2.1Å (R-free/R-work
of 18.76%/23.28%), using molecular replacement with hNTHL1∆63 as the search model
(McCoy, Grosse-Kunstleve et al. 2007, Adams, Afonine et al. 2010). To determine the
phases via molecular replacement, the 6 helical barrel domain was placed prior to the
[4Fe4S] domain. By searching with each domain individually, the domains were allowed
the freedom necessary to rearrange relative to each other. The hNTHL1∆63 chimera
crystallized in a closed conformation, with an 83o rotation relative to the apo-open
conformation (Figure 4), similar to unliganded EcoNth (RMSD 2.21 Å), DraNth (RMSD
2.77 Å& 1.84 Å), and GstNth bound DNA (RMSD 1.40 Å). We were unable to
completely trace the hNTHL1Δ63 chimera linker, because of disorder due within the
flexible linker and the N-terminal extension (Figure 4, C). The proximity of these two
disordered regions made it impossible to assign electron density with a high degree of
confidence. Nevertheless, the shortened linker lowered the interdomain flexibility within
the enzyme. The refined B-factor, or temperature factor, provides a measure of the
relative movement of an atom, where higher numbers (shown in warmer colors in the
protein cartoon) signify increased movement. The reduced movement of the enzyme is
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apparent from the B-factors; Not only is the average B-factors lower overall, but the
[4Fe-4S] cluster domain has greatly reduced B-factors in the chimera relative to the open
hNTHL1Δ63 structure (Figure 5).

2.3.3 The closed conformation of hNTHL1∆63 chimera has restored the active site.

In the hNTHL1Δ63 chimera model, the catalytic aspartate and lysine are 5.3Å
apart. They occupy the identical orientation in closed bacterial ortholog structures, with
or without DNA (Figure 4). Closure of the enzyme therefore restores the glycosylase
active site to an apparent active configuration (Figure 4B). By comparing these new
structures of hNTHL1 to prior models of homologs, we suggest that the conformation
change is essential for catalysis. These conformational changes observed in the
hNTHL1Δ63 crystal structures are reminiscent of the conformational changes reported
for EcoNei, which also close upon binding DNA (Zharkov, Golan et al. 2002, Golan,
Zharkov et al. 2005). In the apo-EcoNei structure the C-terminal domain requires a 60o
rotation to form the closed ligand complex (Golan, Zharkov et al. 2005).

2.3.4 The hNTHL1Δ63 chimera has reduced DNA binding and activity
To determine if hNTHL1∆63 chimera retains activity, despite its lack of
apparent conformational freedom, we performed single-turnover (STO) activity assays
and EMSAs. In these assays, the 5’ end of the DNA strand containing the lesions was
radiolabeled with P32. In the STO glycosylase assay, hNTHL1 nicks the DNA backbone
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as the damaged base is removed, forming a single product band on the gel with increased
electrophoretic mobility. The STO assays were quenched with NaOH to examine only the
glycosylase activity. NaOH will resolve the Schiff base and reduce the AP site, resulting
in the lower product band without β-elimination. Alternately, quenching via a formamide
stopping dye yields a single product band representing both glycosylase and lyase
activity, because hNTHL1 must catalyze resolution of the Schiff base and β-elimination.
Figure 6 shows the catalytic scheme for hNTHL1, where k2 is the rate of base excision,
and k3 is the rate of β-lyase activity. We found that the hNTHL1∆63 chimera retains
some activity but is greatly impaired compared to the parental variant (Table 3, Figure 7).
The hNTHL1Δ63 chimera is highly deficient when the lyase reaction is necessary (Figure
7 B, Table 3). The Tg:A substrate did not fit a one-phase exponential association model,
and it was therefore impossible to calculate the rate constant k3 for this substrate. The
EMSAs showed that hNTHL1∆63 chimera has severe difficulty in shifting 50 pM DNA
containing the non-hydrolysable AP site analog, THF, compared to hNTHL∆63 (Figure
8). This finding suggests that the conformational change is crucial for binding DNA.
Taken together, these results indicate that when hNTHL1Δ63 is trapped in the closed
conformation, DNA binding is severely impaired. The deficiencies in glycosylase and
lyase activity likely follow from this DNA binding defect. The reduction in catalytic
activity is most likely do to the impaired DNA binding, because when the chimeric DNA
glycosylase provided with additional time, it cleaves all the DNA substrate in the assay
(Figure 7).
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2.3.5 Orthorhombic Crystals of hNTHL1 with DNA Oligo Diffract to High Resolution
Tiny, birefringent crystals (25 x 25 x 25 μm3) of hNTHL1 complexed to furancontaining DNA diffracted to 2.0 Å and 2.5 Å (Figure 9, Table 4). While processing the
diffraction data, it became evident that there were pathologies within these crystals, due
to a double lattice at low resolution. Molecular replacement with using hNTHL1Δ63 as
search model was thwarted due to non-crystallographic symmetry (NCS) (Figure 10).
The NCS operator (0.5,0.5,0) obstructed assignment of a definitive space group, which
impeded the placement of the protein molecules by molecular replacement. Computation
time was increased, because all conceivable search models needed to be evaluated in all
subgroups of P212121. Furthermore, the Matthew’s Coefficient predicted between 4-8
hNTHL1Δ63 monomers per asymmetric unit, meaning that searches were conducted with
a diminishingly small portion of the total scattering mass. The large degree of movement
between the two domains in the unliganded structures justified searching with each
domain separately, but no solution was obtained. A closed conformation was attempted
using the bacterial Nth models, and later the hNTHL1Δ63 chimera model. Multiple
molecular replacement programs were employed, such as PHENIX, PHASER,
MOLREP, BUCCANER, and SHARP (Bricogne, Vonrhein et al. 2003, Cowtan 2006,
McCoy, Grosse-Kunstleve et al. 2007, Adams, Afonine et al. 2010, Vagin and Teplyakov
2010, Winn, Ballard et al. 2011), but each program failed to place the domains. Due to
the high resolution of the dataset, SHELX was also used to attempt placement based on
anomalous scattering due to the [4Fe4S] cluster, but this was also unsuccessful (Sheldrick
2010, Winn, Ballard et al. 2011).
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2.3.6 Monoclinic Centered Crystal of hNTHL1 with DNA Oligo Diffract at Fe Peak
A second crystal form of hNTHL1Δ63 was obtained with the identical DNA
substrate. These monoclinic centered crystals were slightly larger, 60x40x40 um3,
birefringent, and diffracted modestly to 2.3 Å at 1.033Å wavelength and 3.6 Å at the iron
edge 1.79Å wavelength (Figure 11, Table 4). This crystal had a smaller unit cell and thus
only two molecules were predicted in the asymmetric unit using the Matthew’s
coefficient. The iron edge data were used to phase the [4Fe4S] clusters using SHARP
(Table 5) (Bricogne, Vonrhein et al. 2003). The two [4Fe4S] clusters were phased,
although the maps were not high enough quality to trace the protein backbone (Vagin and
Teplyakov 2010, Winn, Ballard et al. 2011). The poor phasing is most likely due to the
proximity of the clusters, which are located within 25 Å of each other in the asymmetric
unit, and sit adjacent to special positions in the unit cell face. The location of the clusters
were verified by inspection of the Harker sections in the anomalous difference Patterson
maps (Figure 12) (Bricogne, Vonrhein et al. 2003, Winn, Ballard et al. 2011), although
this solution strategy also failed to produce interpretable phasing.

2.3.7 Germline variant G286S has reduced glycosylase/lyase activity
The germline variant hNTHL1 G286S (rs139309757), located in an α-helix in
the [4Fe4S] cluster domain, was first reported in the 1000 Genomes Database (Genomes
Project, Auton et al. 2015), and more recently was found in a patient with familial
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adenomatous polyposis 3 and reported to the NCBI (Figure 13) (Information 2018).
hNTHL1 G286S behaved similarly to WT and purified with the [4Fe4S] intact. We
performed STO and MTO assays to assess the DNA glycosylases glycolytic/lytic ability,
and product release, respectively. hNTHL1 G286S has greatly impaired glycolytic and
lytic activity, as shown by the ~10-fold decrease in the observed k3 for both Tg: A and
DHU: G, and lytic activity on AP: G (Figure 14 A-C, Table 6). The variant hNTHL1
G286S does not have a significantly different kobs under multiple turnover conditions
suggesting that there is not a defect in product release, but the enzyme is unable to cleave
all of the DNA (Figure 14 D-E, Table 6). Taken together, these results suggest that
hNTHL1 G286S is significantly impaired at the chemistry step but not product release.
To determine the effect of the SNP G286S on the folding of the DNA glycosylase, and
the interdomain organization, we crystallized hNTHL1Δ63 G286S. Unfortunately, the
crystals only diffracted to 6Å at best. Further optimization of the hNTHL1Δ63 G286S
crystals is necessary to understand the effect of the mutation at the molecular level.

2.4 Discussion

The first crystal structure of human NTHL1 revealed an open conformation,
with an 83o rotation relative to the closed state, that had not previously been observed in
the bacterial Nth homologs. With this new finding, the HhH family of DNA glycosylases
joins the H2TH and UDG families with crystallographic evidence of gross
conformational change during catalysis (Parikh, Mol et al. 1998, Golan, Zharkov et al.
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2005). This open conformation renders the glycosylase catalytically inactive as the two
active site residues are much too far apart, 23Å, to perform a nucleophilic attack. Thus, a
conformational change must occur upon DNA binding to assemble the active site. We
showed that the interdomain rearrangement is due to the extended linker in the hNTHL1
enzyme. With the substitution of the E. coli linker in hNTHL1∆63, hNTHL1∆63
chimera, crystallized in the closed form, similar to that of bacterial Nth, rescuing the
active site (Katcher and Wallace 1983, Kuo, McRee et al. 1992, Kuo, McRee et al. 1992,
Cunningham, Ahern et al. 1994, Thayer, Ahern et al. 1995, Fromme and Verdine 2003,
Sarre, Okvist et al. 2015). Even though the active site is restored, hNTHL1∆63 chimera
has severely reduced activity, and reduced DNA binding affinity. We saw nearly no
shifting of DNA by hNTHL1Δ63 chimera, in conditions where hNTHL1∆63 parental
variant shifted the DNA robustly. This suggests that the movement between the domains
is critical for DNA binding in vitro.

There are currently two other crystal structures that show interdomain
rearrangement. Human uracil DNA glycosylase (UDG) undergoes a 10o conformational
change, in which the two globular domains move together and “pinch” the DNA, causing
a 45o kink in the DNA backbone (Parikh, Mol et al. 1998). E. coli endonuclease VIII
(Nei) has a much more dramatic 50o interdomain rotation upon binding DNA (Golan,
Zharkov et al. 2005). Interdomain changes are not possible in AAG, because it has a
single domain, but high and low affinity DNA binding states were postulated after
comparing non-equivalent complexes in a single crystal structure. The DNA interacting
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residues of AAG appeared ordered in the high affinity state (Setser, Lingaraju et al.
2012). AAG has yet to be crystallized in the apo-form, and therefore organization of the
DNA interacting residues and intradomain shifting in the absence of DNA is unknown.

Kuznetsov et al. performed stopped flow Trp fluorescence with EcoNth, to
determine if there were gross conformational changes upon DNA addition. They did not
observe a difference in Trp fluorescence, suggesting that there is no interdomain
movement in bacterial Nth, or possibly that the fluorescence signal was quenched by
buffer (Kuznetsov, Kladova et al. 2015). The bacterial Nth crystal structures do not
provide evidence that prokaryotic Nth undergoes gross conformational changes.

The crystal structures of human OGG1, a member of the HhH family, revealed
no precedence for interdomain conformational changes. However, stopped flow Trp
fluorescence shows that the enzyme undergoes pre-incision isomerization (Kuznetsov,
Koval et al. 2007). Due to the limits of the experiment, it is impossible to conclude
whether the change in Trp fluorescence is due to transfer of the 8-oxoguanine from the
exo-site to the active site, an interdomain rearrangement of OGG1, or a mixture of both.
A mixture of both intra- and inter-domain movements substantiates is suggested as the
most likely explanation. Taken together, these examples support the hypothesis that
conformational rearrangement may be present in more HhH family DNA glycosylases
than just hNTHL1.
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Solution studies investigating hNTHL1 isomerization on DNA are a necessary
next step in determining the role of the reported conformational change. Perhaps
hNTHL1 evolved the more flexible, extended linker to allow for greater regulation or
specificity via the interdomain rearrangements? This feature is additional to the unique
N-terminal extension in hNTHL1. The N-terminal extension of hNTHL1 increases the
enzyme’s affinity for DNA (Liu and Roy 2002). When the N-terminal extension is
truncated, hNTHL1 forfeits a portion of DNA binding activity. This enhances the rate of
koff and allows hNTH1 to exhibit biochemical parameters comparable to bacterial
homologs (Liu and Roy 2002, Liu, Choudhury et al. 2003).

hNTHL1 is believed to multimerize, based on crosslinking experiments, and the
emergence of a sigmoidal curve when glycosylase activity is plotted vs enzyme
concentration (Liu, Choudhury et al. 2003). An underappreciated means of enzymatic
cooperativity independent of multimerization is conveyed by the concept of “NonMichaelis-Menten kinetics of monomeric enzymes with a single ligand-binding site”
(Porter and Miller 2012). There are two common monomeric cooperativity models:
mnemonic and Ligand-Induced Slow Transition (LIST). Both models assume that there
are two distinct enzyme conformations, characteristic of a low affinity and high affinity
binding state. The concept behind the mnemonic model is that the enzyme can remember
the conformation of the high affinity state for a period of time after product release, such
that the enzyme can dissociate and rebind new substrate, before switching from the high
affinity state. The LIST model is more generic and assumes that there is a pre-existing
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equilibrium between the two conformations. This equilibrium is substrate concentration
dependent. For both models, the conformational change between affinity states needs to
be slower than substrate turnover.

The most well-documented instance of monomeric enzyme cooperativity (or
kinetic cooperativity if you please) is glucokinase, which exemplifies this particular
kinetic behavior in both kinetic and structural data (Porter and Miller 2012). Glucokinase
performs the first step in glycolysis by phosphorylation of glucose to glucose-6phosphate. Glucokinase comprises two domains, and the active site is formed in the cleft
between those domains. Much like hNTHL1, the glucokinase structures revealed a hinge
region, with a 99o rotation of the two domains between the open and closed
conformations (Kamata, Mitsuya et al. 2004).

When quantifying biochemical reaction

trajectories, glucokinase exhibits positive cooperativity, evident as a sigmoidal curve
relating substrate concentration to rate, in the presence of increasing glucose
concentration, but not ATP (Parry and Walker 1966, Storer and Cornish-Bowden 1976).
Kamata interpreted the crystal structures, postulating the existence of a super-open
ground state conformation that is driven to an open glucose-bound state. This
equilibrium depends on the concentration of glucose but not ATP, and is rate-limiting in
the greater reaction scheme. Sigmoidal reaction curves therefore emerge due to bypass of
this rate-limiting step at high concentrations of glucose, rather than by the conventional
cooperative model which assumes enhanced binding at multiple sites a protein complex.
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Ribonuclease A demonstrated monomeric cooperativity, along similar lines as
glucokinase, with the apo enzyme existing in two states termed E1 and Ea.
Crystallographic and NMR studies of ribonuclease A documented an equilibrium
between inactive and active enzyme conformations, and kinetic data was characteristic of
monomeric cooperativity (Wyckoff, Hardman et al. 1967, Rubsamen, Khandker et al.
1974). In the case of ribonuclease A, a non-covalent, conformational equilibrium between
E1 and Ea is rate-limiting, such that the occupancy of Ea, the active conformation that
binds to substrate, is preferred at higher concentration of the nucleic acid substrate.

Perhaps kinetic cooperativity could govern the kinetic behavior of hNTHL1?
The crystal structures fail to provide a multimerization interface, but rather depict a
conformational change reminiscent of other well-studied enzymes, such as glucokinase
and ribonuclease A. hNTHL1 elutes off the Superdex 75 sizing column as a monomer,
again providing no potential for conventional cooperative behavior. To verify if hNTHL1
exhibits monomeric cooperativity, kinetics with increasing concentrations of hNTHL1
must be evaluated, and analyzed for enzyme hysteresis during the steady state (nonhyperbolic enzyme kinetics).

Currently, there are no reported Hill coefficients supporting the proposed
cooperative reaction model to verify multimerization (Marenstein, Ocampo et al. 2001,
Liu, Choudhury et al. 2003, Marenstein, Chan et al. 2003). Single pair Fӧrster resonance
energy transfer (FRET) could be used to gain structural insight concerning
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conformational changes in hNTHL1 and bolster our interpretation of the X-ray crystal
structure. The FRET model would provide rate constants describing the conformational
change between open and closed. Moreover, analysis of hNTHL1 in solution by FRET
could reveal additional sub-states occurring between the two conformations reported
here. In context with our current understanding of hNTHL1, a semi-open scanning
configuration may be poised for catalysis. Once the rate-limiting scanning complex is
formed, rapid identification and cleavage of the DNA lesion would produce the closed
form. The potential mechanism scheme is illustrated in Figure 15.

The germline variant, hNTHL1 G286S, has significantly impaired function
during catalysis of Tg:A, DHU:G and AP:G during a STO time course. Recently,
Shinmura et. al reported no difference in hNTHL1 G286S activity under STO conditions
(Shinmura, Kato et al. 2019). There are two major incongruencies between our
experiments. First, Shimura et al, only looked at one time point, 30 minutes, and thus
missed the severely impaired burst phase. Second, they quenched with NaOH, where
only glycosylase activity is measured. We quenched with formamide stopping dye,
revealing both glycolytic and β-lytic activity on the gel. hNTHL1 G286S is of interest
because the mutation is located in the [4Fe4S] cluster domain (Figure 13). The helix that
harbors Gly 286 leads to Cys 290 that coordinates the [4Fe4S] cluster. The [4Fe4S]
cluster domain refines with higher average B-factors than the six-helical barrel domain.
The [4Fe4S] cluster domain may necessarily become ordered in the transition state of
chemistry, which could explain why the G286S mutation diminishes activity from a
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location ~11 Å from the catalytic core. A second possibility stems from the observation
that glycine 286 is located near the putative DNA binding cleft, and therefore could
disrupt DNA binding. Another second variant identified in hepatocellular adenoma,
H241N, is also located near G286S, suggesting destabilization of the [4Fe4S] cluster
domain may provide a motif of hNTHL1 deactivation in disease (Figure 13 B). The
crystal structure of hNTHL1 G286S is currently within reach and will provide data
addressing these postulates.

The conformational change we observe in the hNTHL1 crystal structure
encourages a paradigm shift concerning our kinetic model of this DNA glycosylase. The
bacterial homologs that laid the foundation of current theories do not appear to undergo a
conformational change in the available X-ray crystal structures, or in the solution
fluorescence studies (Kuo, McRee et al. 1992, Kuo, McRee et al. 1992, Cunningham,
Ahern et al. 1994, Mol, Kuo et al. 1995, Thayer, Ahern et al. 1995, Fromme and Verdine
2003, Kuznetsov, Kladova et al. 2015). We have established that truncation of the
extended linker in hNTHL1 shifts the equilibrium towards the closed conformation. The
decreased flexibility of hNTHL1Δ63 chimera drastically worsened the binding affinity to
DNA. The hNTHL1Δ63 chimera still retains glycosylase and β-lyase activity, indicating
that the active site is properly formed at some point during an altered catalytic cycle. A
properly designed FRET experiment could establish the dynamics of the interdomain
rearrangements. Finally, the significance of the conformational change must be evaluated

71

in the context of the greater protein complexes of BER, to glean insight how hNTHL1
contributes to genomic stability in human cells.
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2.7 Table and Figure Legends
Table 2-1: Data collection and refinement statistics for the hNTHL1Δ63, hNTHL1Δ63
chimera, and hNTHL1Δ63 SeMet crystals. The highest resolution shell is shown in
parentheses.

Table 2-2: The linker sequences for hNTHL1, EcoNth, and hNTHL1Δ63 chimera. The
human linker was substituted with the EcoNth linker. The last four residues (KVRR) are
an extension of helix B and were therefore left in the hNTHL1Δ63 chimera to not disrupt
folding.

Table 2-3: The rate constants for hNTHL1Δ63 and hNTHL1Δ63 chimera are reported in
this table. The rate constant k2 is the observed rate of glycosylase only activity, quenched
with NaOH. The rate constant k3 is the observed rate of β-lytic activity, quenched with
formamide stopping dye. The rate constants were calculated by fitting the data to a onephase association exponential, Y=Y0 + (Plateau-Y0)*(1-exp(-K*x)). The hNTHL1Δ63

78

chimera is significantly slower at β-lytic activity on DHU:G and Tg:A, and glycosylase
activity on Tg:A but not DHU:G.

Table 2-4: Data collection and processing statistics. The statistics for all data sets
collected on hNTHL1Δ63-DNA cocrystals are shown. The highest resolution shell is
shown in parentheses.

Table 2-5: SHARP phasing statistics are reported. These statistics suggest that the phases
are of reasonable quality and that the iron-sulfur clusters were likely placed correctly.
Ideally, the phasing power should be >1.5 and R-Cullis <0.6 for isomorphous centric
reflections. An R-Cullis of anomalous reflections <1.0 is ideal (Bricogne, Vonrhein et al.
2003).

Table 2-6: The rate constants for hNTHL1 and hNTHL1 G286S are reported in this table.
The rate constant k3 is the observed rate of β-lytic activity under STO conditions. The
rate constant k5 is the observed rate of product release under MTO conditions. The rate
constants were calculated by fitting the data to a one-phase association exponential,
Y=Y0 + (Plateau-Y0)*(1-exp(-K*x)). The hNTHL1 G286S variant is significantly
slower at glycosylase/β-lytic activity on Ap:G, DHU:G and Tg:A, but is not impaired at
product release. All assays were performed three times.
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Figure 2-1: Human NTHL1Δ63 consists of two globular α helical domains. A) The six
helical bundle domain (red) contains the helix-hairpin-helix DNA binding motif (yellow).
The [4Fe4S] cluster domain (blue) has the iron-sulfur cluster (spheres) and [4Fe4S]
cluster binding loop (cyan). B) The 12 α helices are colored from N to C termini
following the rainbow (violet to red). C) The anomalous electron density peaks for
selenomethionine (magenta) match the methionine sites in NTHL1Δ63 (spheres). This
confirms that the open confirmation is present in the crystals.

Figure 2-2: A superposition of hNTHL1Δ63 (purple) with bacterial orthologs EcoNth
(PDB ID 2ABK, green, (Thayer, Ahern et al. 1995) and GstNth bound to DNA (PDB ID
1ORN, gray, (Fromme and Verdine 2003)) highlights the open state. The bacterial
structures overlay whether or not DNA substrate is bound, with the catalytic aspartate and
lysine (shown in sticks) in close proximity. The active site in is not formed in the open
conformation of hNTHL1Δ63 as the catalytic residues are 23Å apart. The glycosylase
must therefore close to perform catalysis.

Fig 2-3. hNTHL1 harbors an extended linker leading to increased flexibility. A)
hNTHL1Δ63 is depicted in cartoon representation (purple) with the residues belonging to
the extended linker shown in magenta. B) A sequence alignment reveals the 11 amino
acid insertion in eukaryotic hNTHL1 compared to prokaryotic Nth. The first seven amino
acids form a short helix and loop, and the last four amino acids extend helix C.
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Figure 2-4: hNTHL1Δ63 chimera adopts the expected closed conformation. A) A
superposition of hNTHL1Δ63 (purple) and hNTHL1Δ63 chimera (salmon) shows that
the closed conformation is achieved when the linker is shortened. The catalytic aspartates
and lysines are shown as sticks. The [4Fe4S] clusters are shown as spheres. B) in this
close up of the active site of the hNTHL1Δ63 chimera the catalytic residues are shown as
sticks, the 2Fo-Fc electron density map as a blue mesh, and waters are shown as spheres.
The catalytic lysine 220 and aspartate 239 are now 5.3Å apart, a distance consistent with
catalysis

Figure 2-5: The hNTHL1Δ63 (A) and hNTHL1Δ63 chimera (B) models are shown in Bfactor putty representation. The warmer the color and thicker the putty, the higher Bfactor. The hNTHL1Δ63 chimera model is much thinner and cooler than hNTHL1Δ63,
indicating that there is less movement in the chimera structure. In both structures the
[4Fe4S] cluster domain has higher B-factors relative to the six-helical barrel domain,
suggesting that the [4Fe4S] cluster domain has more movement.

Figure 2-6: hNTHL1 schematic of product formations. hNTHL1 (E) binds the oxidized
DNA lesion (SOX), upon N-glycosidic cleavage the base is released, and the substrate is
now an abasic site (SAP). During the breakage of the N-glycosidic bond a Schiff base is
created between the enzyme and substrate. hNTHL1 is bifunctional, therefore the β-lytic
activity releases the 3’-end of the β-eliminated deoxynucleotide (P3’). The Schiff base
needs to be resolved before product release in the form of a single strand break (PSB). If
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β-elimination does not occur, then the Schiff base is resolved from the abasic site and the
final product is SAP. The rate constants k1 and k-1 are the forward and reverse rates of
substrate association and dissociation, k2 is the rate of base excision or glycosylase
activity, k3 is the rate of β-elimination activity, k4 and k-4 are the forward and reverse
rates of Schiff base resolution, k5 and k-5 are the forward and reverse rates of product
(single strand break) release, k6 and k-6 are the forward and reverse rates of Schiff base
resolution without β-lyase occurring prior, and k7 and k-7 are the forward and reverse rates
of AP site release or re-association. Adapted from Robey-Bond, 2014.

Figure 2-7: The hNTHL1Δ63 chimera exhibits significantly reduced glycosylase and βlyase activity. In the STO experiments the DNA glycosylase appears to be more
impaired in the β-elimination reaction (B) than the glycosylase reaction (A), but if given
enough time can go to near completioFn.

Figure 2-8: The hNTHL1Δ63 chimera is unable to shift DNA containing THF:G. In A,
the EMSAs for hNTHL1Δ63 and hNTHL1Δ63 chimera were performed with increasing
concentrations of enzyme from 0 to 1750 pM and 50 pM DNA. 6% native
polyacrylamide gels were run at 150 Watts for 2 hours at 4oC. The DNA-hNTHL1
complex is denoted by a * and the ** represents that super shift. Super shifts have been
observed in EMSAs with DNA glycosylases previously and have been suggested to be
due to non-specific binding of a second DNA glycosylase to the DNA oligomer (Prakash,

82

Carroll et al. 2014). B is a quantification of the EMSAs represented at fraction shifted.
The chimera construct is unable to shift an appreciable amount of DNA.

Figure 2-9: hNTHL1Δ63-DNA co-crystals. In A, the small, birefringent crystals (25 x 25
x 25 μm3) are shown in their crystallization drop. The white arrows indicate the location
of individual crystals. In B, the crystal in is a cryo-solution in a cryoloop prior to
exposure to X-rays. In C, the diffraction pattern is shown, with a close-up of the outer
ring in the inset. Diffraction was past 2.0Å.

Figure 2-10: Representation of Non-Crystallographic Symmetry (NCS). Panel A shows a
crystal without NCS. There is no symmetry within the asymmetric unit (ASU); all of the
symmetry can be accounted for by the crystallographic space group. The unit cell is then
repeated in three dimensions to form the crystal. B shows an example of a crystal with
NCS. There is two-fold symmetry within the ASU, which cannot be explained by the
symmetry of the space group.

Figure 2-11: hNTHL1Δ63-DNA co-crystal. In A, the crystal in the cryoloop with cryosolution prior to being exposed to X-rays. In B, the diffraction pattern of the crystal is
shown. This crystal diffracted more modestly (3.2Å) but the data were acquired at a
lower energy wavelength (Fe peak, λ = 1.79 Å).
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Figure 2-12: Harker sections from the anomalous difference Patterson maps were used to
verify the location of the iron sulfur clusters. The locations matched the positions in the
ASU given by SHARP (Bricogne, Vonrhein et al. 2003, Winn, Ballard et al. 2011).

Figure 2-13: hNTHL1 G286S is a germline variant that has been identified in a patient
with familial adenomatous polyposis 3. In A the location of G286S within the [4Fe4S]
cluster domain is highlighted, with a zoomed in insert. In B, an overlay of NTHL1Δ63
chimera and the DNA from GstNth (1ORN, (Fromme and Verdine 2003)) shows the
proximity of G286 to the DNA and fellow cancer variant, H241. The active site is also
labeled with the catalytic residues, Asp 239 and Lys 220.

Figure 2-14: hNTHL1 G286S is a germline variant that has been identified in a patient
with familial adenomatous polyposis 3. A-C are STO conditions, with 20 nM DNA
oligonucleotide containing Tg:A, DHU:G, or AP:G with 100 nM enzyme. The variant,
hNTHL1 G286S, is significantly inhibited compared to WT. D-E are MTO conditions, 20
nM DNA oligonucleotide containing Tg:A, DHU:G or AP:G with 20 mM enzyme. The
hNTHL1 G286S variant is not able to completely cleave all of the DNA but the kobs are
not significantly different. These data suggest that hNTHL1 G286S is deficient in
glycosylase/β-elimination but not product release.
Figure 2-15: The NTHL1 reaction scheme from figure 6 is expanded to show
conformational states. The ground state Eopen passes through a conformational change
step to Escan when bound to DNA (SDNA). The rate constants k1 and k-1 describe this rate
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limiting conformational change. This lower affinity state scans the DNA, and upon
encountering a DNA lesion (Sox), NTHL1 undergoes a second conformational change to
Eclosed, the catalytically active form. The rest of the reaction scheme follows as before
except product release is also accompanied by a conformational change.
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2.8 Tables and Figures
hNTHL1Δ63

hNTHL1Δ63
chimera

hNTHL1Δ63
SeMet

P 63

P 21 21 21

P 63

124.8 124.8 42.25

42.37 71.68 86.52

125.0, 125.0, 42.4

90 90 120

90 90 90

90 90 120

Wavelength (Å)
Resolution range
(Å)
R-merge

1.033

1.033

0.9795

36.03 - 2.4

37.04 - 2.1

30 - 3.195

3.7 (40)

9.6 (37.4)

10.6 (55.6)

CC1/2

99.3 (30.0)

99.5 (84.3)

97.6 (16.7)

I/sigma

7.2 (1.4)

8.9 (3.4)

12.1 (2.87)

Completeness (%)

1.00

1.00

1.00

Multiplicity

22.2 (22.3)

4.1 (4.0)

8.4 (8.5)

Refinement
Resolution range
(Å)
R-work/R-free (%)

36.03 - 2.4

37.04 - 2.1

19.90/23.08

18.76/23.28

No. reflections

33,2813 (34,904)

64,764 (5,126)

Protein

1,785

1,706

Ligands

8

20

Water
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256

0.002

0.001

0.42

0.39

90.98

30.17

Protein

91.56

28.92

Ligands

71.81

42.22

Data Collection
Space group
Cell dimensions
a,b,c (Å)
o

α,β,γ ( )

No. atoms

RMS Deviations
Bond lengths (Å)
o

Bond angles ( )
B-factor (Å2)

Water

83.24
37.54
Table 2- 1: hNTHL1 Data Processing and Refinement Statistics
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Construct

Linker Sequence

hNTHL1Δ63

VDHLGTEHCYDSSAPKVRR

hNTHL1Δ63 chimera

TTELNFSSPKVRR

EcoNth

TTELNFSSP
Table 2- 2: hNTHL1 Chimera Sequence
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hNTHL1Δ63
hNTHL1Δ63 Chimera

Tg:A
k2 (min-1) k3 (min-1)
3.2
0.46
0.11
n/a

Table 2- 3: Single turnover experiments with hNTHL1Δ63 and hNTHL1Δ63
chimera
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Space group

D1

D2

B1

B1-FePeak

P212121

P212121

94, 136.7,

94, 136.7,

136.5 94.7

151.6

151.6

85.4

90 90 90

90 90 90

90.0 123.7

C2

C2

Cell
dimensions
a,b,c (Å)

α,β,γ (°)

136.5 94.7 85.4

90.0 123.7 90.0

90.0
Wavelength

1.03

1.03

1.03

1.74

Resolution (Å)

50 (2.5)

50 (2.0)

50 (2.3)

50 (3.62)

R-meas (%)

12.3 (24.6)

15.6 (48.5)

7.0 (31.6)

10.96 (33.51)

CC1/2

0.996 (0.835)

0.991 (0.746)

0.996 (0.835 )

99.7 (97.6)

I/sigma

10.5 (1.58)

8.9 (2.14)

8.25 (2.64)

12.47 (5.09)

Completeness

88.5 (40.8)

97.8(84.6)

95.4 (94)

98.4 (91.1)

4.2 (2)

4.4 (3.3)

2.08 (1.97)

3.11 (2.19)

(Å)

(%)
Multiplicity

Table 2- 4: Data collection statistics NTHL1Δ63 co-crystals with DNA
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Phasing Power
R-Cullis

ISO acentric
0.82
0.716

ISO centric
1.295
0.833

Table 2- 5: SHARP phasing statistics
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ANOM acentric
0.63
1.002

STO kobs (min-1)

MTO kobs (min-1)

DHU:G *

Tg:A *

Ap:G *

Ap:G *

DHU:G

Tg:A

hNTHL1

3.79 +/0.57

4.53 +/0.42

5.53 +/0.51

0.10 +/0.0078

0.092 +/0.018

0.080 +/0.0093

hNTHL1
G286S

0.47 +/0.038

0.463 +/0.039

1.76 +/0.10

0.050 +/0.0033

0.025 +/0.021

0.035 +/0.014

Table 2- 6: hNTHL1 and hNTHL1 G286S Rate Constants derived from single- and
multiple turn over experiments
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Figure 2- 1: Structural overview of hNTHL1
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Figure 2- 2: Superposition reveals interdomain movement
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Figure 2- 3: The N-terminal linker is longer in hNTHL1
compared to bacterial Nth.
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Figure 2- 4: The closed conformation of hNTHL1Δ63 chimera assembles
the active site.
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Figure 2- 5: The closed conformation is more rigid.
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Figure 2- 6: hNTHL1 Schematic of enzymatic steps
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Figure 2- 7: Glycosylase and lyase activity assays
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Figure 2- 8: hNTHL1Δ63 chimera has severe DNA binding defect.
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Figure 2- 9: hNTHL1Δ63-DNA co-crystals diffract at
high resolution.
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Figure 2- 10: Representation of Non-crystallographic Symmetry
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Figure 2- 11: Data were collected at the Fe peak on a
hNTHL1Δ63-DNA co-crystal
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Figure 2- 12: Two Harker Sections from Anomalous Difference Patterson map
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Figure 2- 13: The location of G286 is highlighted in the hNTHL1Δ63 crystal
structures
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Figure 2- 14: Comparison of hNTHL1 FL G286S Activity Assays with hNTHL1 FL
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Figure 2- 15: NTHL1 reaction scheme with conformational changes
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3.1 Abstract
In eukaryotes, tRNAs must be modified at the 5’ end during maturation. tRNAHis
guanylyltransferase (THG1), an essential gene in yeast, catalyzes the addition of guanine
to the 5’ of tRNAHis via reverse polymerization. The archaeal TGH1-like proteins (TLPs),
are structural homologs of THG1, but serve distinct biological functions. The TLPs have
been identified as the polymerase responsible for the repair of 5’-degraded tRNA
molecules by reverse 3’5’ NTP-polymerization. Reverse polymerization requires
adenylation (or guanylation) to activate the 5’ end of the tRNA. After adenylation, there
is a shift of the 5’-phosphate of the tRNA to accommodate the forthcoming nucleophilic
attack by the 3’-OH of the incoming nucleotide. We have solved a crystal structure
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describing this guanylated intermediate: The base rotates within the activation binding
site to align the 5’ phosphate of the tRNA and the 3’OH of the incoming nucleotide in the
active site for nucleotidyl transfer.

3.2 Introduction

The enzyme tRNAHis guanylyltransferase (THG1) is a reverse polymerase, which
modifies the 5’ end of tRNAHis with the addition of G at the n-1 position (Cooley, Appel
et al. 1982, Gu, Jackman et al. 2003). Recognition of tRNAHis by histidyl-tRNA
synthetase requires G at the 5’ end, with rare exceptions in some α-proteobacteria and
protozoans (Cooley, Appel et al. 1982, Gu, Jackman et al. 2003, Wang, Sobral et al.
2007, Yuan, Gogakos et al. 2011, Rao, Mohammad et al. 2013, Rao and Jackman 2015).
In eukaryotes, the primary function of THG1 is to add G in the n-1 position of tRNAHis
across from A73 (Cooley, Appel et al. 1982, Gu, Jackman et al. 2003). In bacteria and
archaea, the precursor tRNA includes a transcribed G across from C73, and upon
cleavage by ribonuclease P yields G-1. Therefore, the canonical activity of THG1 is not
strictly required in non-eukaryotic species (Orellana, Cooley et al. 1986, Burkard, Willis
et al. 1988, Sprinzl and Vassilenko 2005). TLPs (THG1-Like Proteins) differ from bona
fide THG1 in three major ways: 1) TLPs add nucleotides in a Watson-Crick fashion
(Abad, Rao et al. 2010, Rao, Maris et al. 2011), 2) TLPs prefer to add to a truncated 5’
tRNA, rather than full-length (Rao, Maris et al. 2011), and 3) TLPs will extend substrates
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other than tRNAHis exclusively (Jackman and Phizicky 2006, Abad, Rao et al. 2010,
Abad, Long et al. 2011, Rao, Maris et al. 2011, Abad, Long et al. 2014). TLPs are not
only functionally unique, but also phylogenetically different from THG1, belonging to a
second class of enzymes (Heinemann, O'Donoghue et al. 2009, Heinemann, Nakamura et
al. 2012, Jackman, Gott et al. 2012).

Currently, there are crystal structures of human and yeast THG1, as well as
bacterial and archaeal TLP. Both THG1 and TLP adopt a similar fold and crystallize in a
tetrameric state composed of a dimer of dimers (Hyde, Eckenroth et al. 2010, Hyde, Rao
et al. 2013, Nakamura, Nemoto et al. 2013, Kimura, Suzuki et al. 2016). The first crystal
structure of any THG1 or TLP enzyme was hTHG1. hTHG1 was crystallized in the
presence of dGTP, with a complete dGTP visible in the activation site and a triphosphate
tail visible in the incoming nucleotide binding site. This structure provided the first
indication that THG1 harbors two distinct nucleotide binding sites (Hyde, Eckenroth et
al. 2010).

The first crystal structure of a TLP enzyme was Bacillus thuringinesis TLP,
which crystallized in the presence of GTP. The BtTLP structure has the entirety of both
GTPs visibly bound in the activation and incoming nucleotide binding sites, providing
definitive proof for two separate nucleotide binding locations in a single TLP molecule
(Hyde, Rao et al. 2013). The Candida albicans THG1 tRNAHis crystal structure revealed
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that eukaryotic THG1 enzymes binds RNA across the dimer interface in a 4:2 ratio, such
that one THG1 monomer is bound to the 5’ acceptor stem of tRNAHis and the other
THG1 monomer binds the His anticodon, GUG (Figure 1A) (Nakamura, Nemoto et al.
2013). The archaeal Methanosarcina acetivorans TLP structure revealed an alternate
binding mode, in which the tRNA binds with the 4:2 ratio but almost perpendicular the
position observed in the CaTHG1 structure (Figure 1B) (Nakamura, Nemoto et al. 2013,
Kimura, Suzuki et al. 2016). Interestingly, the two tRNA molecules bound to the TLP
tetramer interact by only the acceptor stems, leaving the anticodon solvent exposed
(Kimura, Suzuki et al. 2016). The differences in tRNA binding mode further separate the
TLPs from the THG1s as a distinct class of enzymes.

For the addition of a ribonucleotide in the 3’  5’ direction, the tRNA strand
needs to be activated by the addition of a nucleotide monophosphate, donated by ATP or
GTP (Figure 1.7 Introduction) (Hyde, Eckenroth et al. 2010, Nakamura, Nemoto et al.
2013). Nucleotide preference varies between THG1 and TLP, but for the remainder of
this manuscript we will focus on TLPs, which favor GTP (Hyde, Rao et al. 2013). Due to
the numerous sequential binding events, the TLP active site accommodates up to 7
different phosphates over the course of catalysis (Figure 2) (Rao, Maris et al. 2011).
Kimura et al. crystallized the archaeal MaTLP alone, with a ribonucleotide, with
tRNAHis, and with tRNAHis plus GDPNP, a stable analog of GDP that TLP cannot
incorporate into the tRNA. A superposition of the MaTLP structures shows that for
nucleophilic attack from the 3’-OH of the incoming NTP, the two phosphates in the
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adenylated tRNA must shift to accommodate a productive active site geometry (Figure 3)
(Kimura, Suzuki et al. 2016). This observation infers that the activating purine base must
also shift, as the phosphates move out of the activating nucleotide binding site. We
crystallized the archaeal Methanobrevibacter smithii TLP in the presence of ATP, GTP
or GTP and a 26-mer hairpin RNA. Our crystal structures show that MsTLP is a dimer of
dimers, as reported for all other THG1 and TLPs to date (Figure 4). In our structures, we
see the NTP in its entirety bound to the activation site, but only a single phosphate at the
incoming nucleotide binding site. When crystals are soaked with a 26-mer hairpin RNA
(hpRNA), the activating GTP is resolved in a novel conformation, where the base has
rotated. This shift pinpoints amino acid contacts that might bring about the movement of
the tRNA acceptor stem from the activation site to the nucleotide addition site.

3.3 Materials and Methods
3.3.1 Protein Purification and Expression

MsTLP, with a 3C protease cleavable N-terminal (His)6 tag, was overexpressed in
Escherichia coli Rosetta2 (DE3) pLysS cells (Novagen) using the Studier autoinduction
method (Studier 2005). Briefly, a single colony was grown in 1L of Terrific Broth
(ThermoFisher) containing 1X 5052 mix (0.05% glucose, 0.2% lactose, 0.5% glycerol),
Ampicillin, and Chloramphenicol, for 60 hrs at 20°C. The E. coli cells were lysed by
sonication in 20 mM HEPES pH 7, 1 M NaCl, 10% Glycerol, 4mM MgCl2, 0.5 mM B111

me, 1 mM PMSF. Lysate was clarified by centrifugation for 45 minutes at 23,425 x g.
The clarified lysate was first diluted to 500 mM NaCl using 20 mM HEPES pH 7, 40 mM
imidazole, 10% Glycerol, 4mM MgCl2, 0.5 mM beta mercaptoethanol (B-me) and
purified over nickel-NTA resin (ThermoFisher) with a stepwise gradient of 30 mM, 50
mM, 75 mM, 250 mM, and 500 mM imidazole. The N-terminal (His)6 tag was cleaved at
room temperature overnight with equimolar ratio of 3C protease:MsTLP during dialysis
into 20 mM HEPES pH7, 300 mM KCl, 4 mM MgCl2, 10% glycerol and 5 mM B-Me.
MsTLP was purified away from the 3C protease and (His)6 tag by flowing over nickelNTA resin. MsTLP was further purified over a 1mL Heparin column (GE Healthcare), 20
mM HEPES pH 7, 300 mM KCl, 10% Glycerol, 4mM MgCl2, 1mM DTT, with a 30
column-volume elution gradient from 300 mM to 1M KCl. The final storage buffer was
20 mM HEPES pH 7, 500 mM KCl, 10% Glycerol, 4mM MgCl2, 1mM DTT. MsTLP
was found to be cold sensitive (4°C); therefore, all of the purification steps were done at
room temperature (22°C). MsTLP was concentrated to 3.8 mg/ml (Millipore Amicon
Ultra-15), flash frozen in liquid nitrogen, and stored at -80°C.

3.3.2 Crystallization

MsTLP crystals were optimized from an initial hit in Crystal Screen 2 (Hampton
Research), condition G8, 0.1M NaCl, 0.1M HEPES pH 7.5, 1.6M ammonium sulfate.
Tetragonal crystals were grown using vapor diffusion with 1μL MsTLP (3.8 mg/ml)
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preincubated with 5mM ATP and 1μL reservoir 2M NaCl, 0.5-1.6M ammonium acetate
(AmOAc), 35% Tacsimate, 0.1M HEPES pH 7.5, 1% Sucrose. The conditions were
optimized from the original hit in Crystal Screen 2 G8, 0.1M NaCl, 0.1M HEPES pH 7.5,
and 1.6M AmSO4. Crystals grew to approximately 200x200x200μm3 diamonds. Crystals
were transferred into a cryoprotectant composed of 50% reservoir and 50%
cryoprotectant solution consisting of 1M NaCl, 3.5M Tacsimate, 10μM ATP, 10μM
Hepes pH 7.5, 6.0% w/v glycerol, 0.5μM TCEP. For the crystals used in phasing NaCl
was substituted with NaBr or NaI. The crystals were cryo-cooled in LN2.

Orthorhombic crystals were grown using the vapor diffusion method with 1μL
MsTLP (3.8 mg/ml) preincubated with 5mM GTP and 1μL reservoir 4M NaCl and 0.1M
HEPES pH 7.5. Crystals grew to approximately 500x150x100μm. Crystals were
transferred into a cryoprotectant of 50% reservoir and 50% 1M NaCl, 3.5M Tacsimate,
10μM GTP, 10μM HEPES pH 7.5, 0.005% w/v glycerol, 0.5μM TCEP. For the GTP
structure with RNA, the small hairpin RNA, 5’P
GCGGAUUCUGAAAAGAAUUCGCCAAA, was added prior to cryoprotectant. The
crystals were cryo-cooled in LN2.
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3.3.3 Structure Determination

The MsTLP crystallographic data were collected at the Diamond Light Source
(beamline MX, Pilatus3 6M detector) and our in-house X-ray source copper rotating
anode generator (Rigaku RU-H3R ) with the Mar345 image plate detector. Data on the
ATP-bound crystals grown in the presence of sodium bromide were collected at APS at
1.03Å wavelength. Data on the GTP crystals grown in the presence of sodium iodide
were collected on the rotating anode home source (MARResearch). The ATP- and GTPbound crystals grown in the presence of sodium chloride were collected at the Diamond
Light Source (beamline MX, Pilatus3 6M detector) at 1.033Å. The NaBr-MsTLP-ATP
data were collected at 0.92Å. The NaI MsTLP-GTP data were collected on our X-ray
home source, at 1.54Å. The NaCl- MsTLP ATP structure was solved with the NaBrMsTLP-ATP and NaI MsTLP-GTP data, using via multiwavelength anomalous
diffraction (MAD) settings PHENIX.AUTOSOL, as the crystals were isomorphous
(Adams, Afonine et al. 2010). The NaCl- MsTLP-GTP structures were solved via
molecular replacement with the NaCl-MsTLP-ATP model. All structures were modeled
using COOT and refined using PHENIX.REFINE.
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3.4 Results
3.4.1 Structure Description

MsTLP crystals were obtained in the presence of either ATP or GTP. The ATP
crystals were tetragonal and diffracted to 2.1 Å. A GTP-crystal was soaked in the
presence of a hpRNA, yielding a GTP-RNA crystal. The GTP crystals were obtained in
both orthorhombic space group and diffracted to 2.5 Å (GTP-RNA) and 2.75 Å (GTP
alone) (Table 1). The crystal drops contained two crystal shapes, rectangular and
diamond-like. The rectangular crystals indexed as orthorhombic, and the diamond-like as
tetragonal. The cell parameters suggested that the crystals were cubic, with a=b=c and α,
β,γ = 90o, but the merging the data suggested the true space groups was of lower
symmetry. The GTP-RNA crystal indexed as tetragonal, but the refinement stalled until
the true orthorhombic space group was selected. The ATP-bound structure was solved
using a MAD-like approach, with bromine and iodide crystals. The GTP-bound crystals
were solved by molecular replacement, searching with the ATP-bound model.

M. smithii TLP is composed of 239 amino acids with a predicted molecular
weight of 27,800 Daltons. The archaeal protein crystallized as a tetrameric dimer of
dimers, as seen in the all previous bacterial, yeast, and human paralogs (Figure 4). By
superimposing models, it is apparent that the M. smithii monomer resembles the bacterial
TLP (RMSD 1.06 Å to BtTLP PDB ID 4KGK) more so than human THG1 (RMSD of
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2.08 Å to hTHG1 PDB ID 3OTB). Calculating the buried surface area for the molecular
interfaces shows that there is a strong interaction between the monomers of the dimer
(buried surface area of 2172.96 Å2) , and a somewhat weaker interface between the
dimer of dimers with a (buried surface area of 1335.86 Å2) (Bliven, Lafita et al. 2018).
This weak interface between the dimer of dimers may be necessary for subtle structural
rearrangements facilitating tRNA binding, as was reported as a rotation within the
MaTLP tetramer (Kimura, Suzuki et al. 2016).

3.4.2 Two GTP conformations were observed

Our MsTLP structures are similar to the previously crystallized TLPs in
secondary, tertiary, and quaternary structure. The nucleotide bindings sites and the
arrangement of residues in active site of MsTLP are reminiscent of the TLPs crystallized
prior. The activating nucleotide was observed with two metal ions bound (Mg2+ ) in the
MsTLP structures, suggesting that the mechanism of action is similar to that previously
described (Jackman and Phizicky 2006, Hyde, Eckenroth et al. 2010, Abad, Long et al.
2011, Rao, Maris et al. 2011, Kimura, Suzuki et al. 2016). Interestingly, one of the GTP
molecules is observed in an alternate conformation in the crystal that was soaked with a
hpRNA (Figure 4, Figure 5 A and C and Figure 6). The crystals grown in the presence of
ATP or GTP without soaking in RNA before cryocooling have both nucleotides bound in
the same orientation in the nucleotide activation site, as has previously been reported
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(Figure 5 and Figure 6). This observation shows that the novel conformation of the
guanine comes about due to the guanylation of the hpRNA during soaking. We chose to
soak in a small hpRNA because TLPs are known to possess activity on RNAs other than
tRNAs, which are typically reticent to crystallization (Abad, Long et al. 2011).

These alternate GTP conformations have different amino acid contacts: Asn139
contacts the N2 of the GTP when the guanosine base has rotated within the first binding
site. This contact would not be seen if ATP was bound in a similar manner (Figure 6 A,
Figure 7). This is consistent with the fact that some TLPs prefer GTP for the activation
step (Chen, Jayasinghe et al. 2019). Two other residues, Tyr40 and Phe44, make stacking
interactions with the GTP base. There is a π-bond interaction between the N1 of the GTP
and the benzene ring of Tyr40. Phe 44 stabilizes the rotated base by stacking on top of the
GTP.

The single 5’G of the incoming hpRNA is guanylated in monomer A, but the rest
of the hpRNA is disordered. hpRNA is not the native substrate for MsTLP, and its
disorder in the structure is therefore not surprising. A single phosphate of the incoming
nucleotide at the nucleotidyl transfer site is visible in all three crystal forms. The
remaining atoms of incoming nucleotide are disordered, perhaps due to the lack of a
Watson-Crick base pair stabilizing the base, as was proposed for hTHG1 (Hyde,
Eckenroth et al. 2010). The fact that the reaction stalled after guanylation of the hpRNA
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might be due to the fact that crystal contacts resist rotations within the TLP tetramer
necessary for subsequent catalytic progression.

3.5 Discussion

The novel GTP conformation seen in the MsTLP crystal soaked with hpRNA
illustrates that the base rotates within the binding pocket after guanyulation, to prepare
the enzyme for 3’5’ polymerization. An overlay of the MaTLP crystal structures
demonstrates that the tRNA must shift upon the guanylation of the 5’tRNA to allow for
the Watson-Crick directed nucleotidyl transfer (Kimura, Suzuki et al. 2016). The 3’OH of
the second nucleotide would clash with the α-phosphate of the tRNA if no movement
occurred (Figure 2 and Figure 3). Our crystal structure implicates three residues, Tyr40,
Phe44, and Asn139, as key residues in stabilizing the rotated base (Figure 7). These
residues are highly conserved from archaea to bacteria to yeast to humans. The strictly
conserved residue, Asn 139, has two important contacts: 1) the specific interaction of
Asn139 with N2-of the GTP, and 2) the interaction with the 5’ phosphate of the
guanylated tRNA (Figure 7). Unlike THG1, TLPs have been shown to prefer activation
with GTP, perhaps due to the stabilization of the rotated guanine in the activation site
(Chen, Jayasinghe et al. 2019). The interaction with the 5’ phosphate of the tRNA may
be involved in rearranging and stabilization of the guanylated tRNA for nucleotidyl
transfer. Tyr 40, and Phe 44 are the least conserved residues of the four, although they
are highly conserved in archaea, with Tyr 40 being Asn in human and yeast, and Phe in
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bacteria. Phe 44 corresponds to Ala in the THG1 enzymes and Leu in BtTLP. These
aromatic residues make non-specific, yet potentially important contacts with the rotated
guanine. A fourth highly conserved residue, Met48 (Met in yeast and humans, and Phe in
BtTLP), is located in an aromatic pocket that orientates Tyr40 and Phe44 (Figure 7).
Mutation of Met 48 residue may alter the orientation of Tyr40 and Phe44, destabilizing
the rotated base. If the rotated base is not stabilized, TLP may not be able to
accommodate the second nucleotide, due to steric clashing between the 5’ α-phosphate of
the RNA and 2’OH on the ribose of the incoming nucleotide. Sorting Intolerant From
Tolerant (SIFT)(Ng and Henikoff 2001) predicts that any alteration to Met48 and Asn
139 would not be tolerated by MsTLP (Kumar, Henikoff et al. 2009). Polyphen 2
predicts that the all of the suggested mutations would be damaging (Adzhubei, Schmidt et
al. 2010). To confirm the importance of these amino acids, MsTLP mutants Y40A, F44A,
M48A, and N139A could be tested for activity with ATP, GTP and ITP during the
charging of tRNAs for reverse polymerization. These biochemical assays would confirm
the necessary points of contact from the TLP polymerase to its substrates during
catalysis.

The residues homologous to MsTLP Asn 139 and Tyr 40 have been studied in
Saccharomyces cerevisiae THG1 (Jackman and Phizicky 2008). Superposition of yeast
THG1 (3WC0, (Nakamura, Nemoto et al. 2013)) and MsTLP-GTP-RNA, showed that
CaTHG1 Asn 46 corresponds to MsTLP Tyr 40, which interacts with the N1 of the
guanine base. This interaction would be compatible with adenine, as ATP is preferred for
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tRNA activation by THG1 (Chen, Jayasinghe et al. 2019). Mutation of N46 was shown to
have only ~20% of the G-1 addition activity of wildtype ScTHG1, although N46A was
able to complement the ScTHG1 knock-out, suggesting that ~20% of the activity
adequate to support life. ScTHG1 N157A (N139 in MsTLP) could only partially
complement ScTHG1-/-, and was shown to have <3% G-1 addition activity. This suggests
that Asn 157 plays a more critical role in preparing for nucleotidyl transfer than Asn 46
(Jackman and Phizicky 2008). The MsTLP crystal structure fits with these conclusions,
as Asn 139 makes a specific hydrogen bond to the guanylated tRNA, and a hydrogen
bond with the 5’ phosphate of the tRNA.

Details of the reverse polymerization mechanism could be elucidated through
time lapse crystallography. MsTLP would be a prime candidate for this technique, as we
were able to soak in hpRNA, and capture the guanylated-tRNA intermediate. With the
plethora of TLP structures available now, a truncated tRNA could be designed that would
be both small enough to soak into the crystals, and large enough to be make stable
contacts with the TLP. The knowledge to be gained about the rearrangements of protein
residues and nucleic acids during reverse polymerization would greatly aid in the
understanding of mechanism of tRNA repair by TLPs. The potential pitfall of this
approach stems from the likelihood that long-range rearrangements in the TLP tetramer
might be impossible in crystal form.
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The MsTLP-hpRNA structure identified rotation of the guanine base in the
activation site upon guanylation. Our structure is the first visualizing a guanylated RNA
undergoing non-covalent rearrangements required to prepare the active site for reverse
polymerization. This novel structure identified amino acid residues important for
stabilization of the guanylated substrate prior to nucleotidyl attack from the incoming
NTP. We have additionally demonstrated that hpRNA can be soaked into the crystals,
which could serve as the foundation for future crystallography experiments.
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3.7 Table and Figure legends
Table 3-1: Data collection and refinement statistics for the MsTLP crystals. High
resolution statistics are in parentheses.

Figure 3-1: Both TLP and THG1 have been crystallized bound to tRNAHis. In A CaTHG1
bound to tRNAHis (3WC1, (Nakamura, Nemoto et al. 2013)) is depicted in cartoon
format. The tRNAHis interacts with three monomers in the THG1 dimer of dimers. The 5’
and 3’ acceptor stems interact in with the monomers of the dimer and the anticodon
extends into one monomer of the adjacent dimer. In B MaTLP binds to tRNAHis (3AXN,
(Kimura, Suzuki et al. 2016)) shown as cartoon, in a perpendicular direction relative to
CaTHG1. The tRNAHis interacts with only the monomers A&B or C&D.

Figure 3-2: The TLP mechanism is depicted above, with emphasis on the phosphate
locations and movements. The α phosphate on the tRNA binds in phosphate site 1, and
the α, β, and γ phosphates of the incoming activation nucleotide will bind in sites 2, 3,
and 4, respectively. Upon nucleophilic attack from the α phosphate of the tRNA, the
pyrophosphate group leaves. The activated tRNA will need to translocate from phosphate
sites 1 and 2 to sites 2 and 3, to allow the second base pairing nucleotide to bind. This
translocation is necessary because of the proximity of the 2’OH of the incoming
nucleotide to phosphate site 1. In order for this translocation to occur, the base of the
nucleotide used to charge the tRNA will also need to move within the nucleotide binding
pocket. After translocation, the incoming nucleotide can bind (phosphate sites 5, 6, and
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7), and nucleophilic attack from the 2’OH can happen. The AMP or GMP moiety then
leaves, leaving a triphosphate group at the end of the tRNA. The α, β, and γ phosphates of
the tRNA will occupy sites 1, 2, and 3. Upon binding of the next incoming nucleotide the
α, β, and γ phosphates of the tRNA will translocate to sites 2, 3, and 4. This cycle can
repeat until the tRNA is complete.

Figure 3-3: The suggested seven phosphate binding sites can be seen in an overlay of the
MaTLP structures. The MaTLP tRNAHis bound (magenta, 5AXN; (Kimura, Suzuki et al.
2016)) shows site 1. MaTLP GTP bound (cyan, 5AXL; (Kimura, Suzuki et al. 2016))
depicts sites 2, 3, and 4. MaTLP bound to tRNAHis with incoming GPNPP (green,
5AXM; (Kimura, Suzuki et al. 2016)) depicts sites 2, 3, and 4, and sites 5, 6, and 7. The
MaTLP structures show that there is a translocation of the tRNA from sites 1, 2, and 3 to
2, 3 and 4, but this guanylated intermediate structure is missing.

Figure 3-4: The THG1 and TLP enzymes form a dimer of dimers. In A MsTLP, in
cartoon representation colored by chain, chain A in red and chain B in blue. Chain A and
B are related by a two-fold forming the strong dimer interface. A second two-fold is
formed by the AB dimer with another AB dimer symmetry mate. The activation
nucleotide binding site is shown by yellow spheres for the GTP. In B BtTLP (4KGK,
(Hyde, Rao et al. 2013)) is depicted in cartoon format, colored by chain, chain A (cyan)
& chain B (green) and chain C (yellow) & chain D (magenta) form the strong dimer
interface. The weak dimer interface is between chain AB and chain CD dimers. The GTP
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(orange spheres) is shows both the activation and nucleotidyl nucleotide binding sites. In
C hTHG1 (3OTB, (Hyde, Eckenroth et al. 2010)) represented by cartoon is colored by
chain, chain A (cyan) and chain B (green) form the dimer interface. The dimer of dimer
interface is created between symmetry mates as like MsTLP. The dGTP bound in the
activation site is shown as orange spheres. The quaternary structure is similar for all
THG1/TLPs crystallized to date (Hyde, Eckenroth et al. 2010, Hyde, Rao et al. 2013,
Nakamura, Nemoto et al. 2013, Kimura, Suzuki et al. 2016).

Figure 3-5: Electron density of the 2FO-FC map (grey mesh) is shown for the nucleotides
within the active site in the MsTLP-GTP-RNA and MsTLP-GTP structures. In A the
protein backbone is depicted by cartoon (light green) and there is density for the 5’G of
the hpRNA (blue sticks) but not the remainder of the RNA strand. This is probably due to
the flexibility of the RNA and weak crystal contacts. The guanine base of the GTP used
to activate the hpRNA is rotated compared to the other structures. The leaving group
pyrophosphate (PPi) is still bound in the active site. The Mg2+ ions are shown as green
spheres. The phosphate of the incoming GTP can be seen in the nucleotidyl transfer
nucleotide binding pocket. In B the MsTLP protein backbone is represented in cartoon
format (light pink) and the GTP (yellow) is seen in the previously reported conformation.
The Mg2+ ions are shown as green spheres. The γ phosphate for the incoming GTP is
visible but not the remainder of the nucleotide. The lack of resolution of the incoming
GTP in both structures is most likely due to poor stabilization as it cannot engage in a
Watson-Crick base pair.
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Figure 3-6: The activation nucleotide binding pockets, depicts the 90o rotation of the
guanine after guanylation relative to ATP and GTP. The MsTLP backbone is shown in
green cartoon, the guanylated - 5’ tRNA is colored in purple sticks, GTP in yellow sticks,
and ATP in cyan sticks. the rotation of the guanine base relative to ATP (cyan sticks) is
shown.

Figure 3-7: Upon the addition of a hpRNA, the guanine (blue) rotates in the activation
nucleotide binding pocket and is stabilized specifically by Asn 139 (2.8Å) via a
hydrogen bond and by stacking interactions with aromatic residues Tyr 40 and Phe 44.
Met 48 is a highly conserved residue that helps orientate Phe 44. Asn 139 also forms a
hydrogen bond with the 5’ phosphate of the guanylated tRNA (blue, 3.2Å). The specific
hydrogen bond interaction between Asn 139 and guanine would not take place with
adenine, giving a structural rationale as to why TLPs prefer GTP (Chen, Jayasinghe et al.
2019).
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3.8 Tables and Figures
TLP-ATP

TLP-GTPRNA

TLP-GTP

TLP-ATP
Bromide

TLP-GTP
Iodide

P 42 21 2

P 21 2 21

P222

P42 21 2

P42 21 2

a,b,c (Å)

84.6 84.6 84.7

84.13 84.5 84.6

83.2 83.4 125.0

84.9 84.9 84.6

85.3 85.3 85.8

α,β,γ (°)

90 90 90

90 90 90

90 90 90

90 90 90

90 90 90

Data collection
Space group
Cell dimensions

Wavelength (Å)

1.033

1.033

1.033

0.92

1.54

Resolution range (Å)

3.0 (53.4)

5.5 (70.4)

6.4 (1.0)

40 – 2.64

30.0 – 2.6

R-pim

99.9 (55.3)

0.965 (0.41)

99.7 (33.5)

1.9 (26.4)

14.9 (68.6)

CC1/2

13.3 (1.7)

6.3 (0.9)

10.1(1.6)

1.0 (87.1)

98.3 (83.8)

I/sigma

100 (100)

99.6 (99.0)

99.7(100)

28.8 (3.0)

11.2 (2.04)

Completeness (%)

12.7 (13)

5.2 (4.9)

6.4 (6.2)

99.1 (93.8)

96.9 (97.7)

Multiplicity

3.0 (53.4)

5.5 (70.4)

6.4 (1.07)

13.5 (11.8)

7.1 (4.5)

42.3 - 2.1

25.4 - 2.5

19.9 - 2.75

0.179 /0.228

0.226/0.292

0.173 /0.212

Protein

1835

3919

3705

Ligands

38

102

68

Water

203

168

176

Bonds lengths (Å)

0.003

0.003

0.003

Bond angles (°)

0.65

0.53

0.62

Protein

82.48

102

99.55

Ligands

88.52

167

148.67

Water

82.48

109

98.28

Refinement
Resolution range (Å)
R-work/R-free
No. reflections
No. atoms

RMS Deviations

2

B-factors (Å )

Table 3- 1: Data collection and refinement statistics
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Figure 3- 1: THG1 and TLP bind tRNA in perpendicular orientations to each other
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Figure 3- 2: TLP adds ribonucleotides to the 5’ end of tRNA.
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Figure 3- 3: The MaTLP structure reveals seven phosphate sites within the active
site.
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Figure 3- 4: THG1 and TLP form a dimer of dimers
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Figure 3- 5: The guanine base rotates after guanylation of the 5’ tRNA

Figure 3- 6: The GTP rotates within the binding pocket to accommodate the
movement of phosphates upon activation of the 5’ end of a hpRNA
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Figure 3- 7: The rotated guanine is stabilized by conserved residues in the
nucleotide binding pocket
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CHAPTER IV: CONCLUSIONS, SIGNIFICANCE, AND FUTURE
DIRECTIONS
4.1 Conclusions and Significance

This dissertation relied heavily on X-ray crystallography to examine the
catalytic cycles of two nucleic acid repair enzymes: hNTHL1 and archaeal TLPs.
Damage to nucleic acids occur via endogenous and exogenous sources, and nucleic acid
repair mechanisms are essential for proper cellular function and survival. Genetic
information must flow freely from DNA to mRNA to proteins, and nucleic acid repair
processes must integrate into these greater pathways to balance genome stability with
robustness and damage tolerance.

In chapter II, we reported the first crystal structure of the DNA glycosylase
hNTHL1. DNA glycosylases initiate the base excision repair (BER) pathway, which
repairs oxidized and small non-bulky DNA lesions. The crystal structure revealed an
unexpected, novel, open conformation for apo-hNTHL1. The previously crystallized
bacterial Nth models, with and without DNA, did not infer interdomain reorganization.
Solution studies conducted with fluorescent EcoNth suggested that the domains remain in
the same relative orientation, without large conformational changes of the DNA-bound
glycosylase. We imposed the closed conformation onto apo hNTHL1 by truncating a
flexible linker between the two domains and determined its structure by X-ray
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crystallography. This flexible linker was shown to enhance DNA binding in EMSAs. The
linker region is also essential for full activity on Tg:A and DHU:G in STO conditions.

The germline variant hNTHL1 G286S has been identified in a familial
adenomatous polyposis patient and is predicted to be damaging by SIFT and Polyphen 2.
We over-expressed and purified the G286S variant for biochemical experiments and
determined that the mutant enzyme has significantly impaired glycosylase and lyase
activities. Due to its location far from the active site, G286S has little potential to perturb
the glycosylase active site directly. Instead, the closed conformation may be accessed
less frequently when the [4Fe4S] cluster domain suffers from intrinsic disorder. Indeed,
the site of G286S resides near the 4Fe4S cluster, and could therefore deform the native
geometry of the coordinating cysteine residues.

In chapter III, we analyzed crystal structures of the archaeal reverse polymerase,
MsTLP. Unlike 5’  3’ polymerization, reverse polymerization requires the activation of
the 5’end of the tRNA via adenylation or guanylation. We captured the never-before-seen
guanylated RNA intermediate, by soaking crystals of MsTLP with a small hpRNA. This
intermediate revealed a rotation of the guanine base in the activation nucleotide binding
pocket, which must precede rearrangement of the phosphates coordinated by the active
site. The rotation is stabilized by three conserved residues, Tyr 40, Phe 44, and Asn 139.
A fourth highly conserved Met 48 may be involved in orientating Phe 44. The enzymatic
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importance of these residues needs to be established by 5’-guanylation (activation assays)
and reverse polymerase primer extension assays.

4.2 NTH Future Directions

4.2.1 Does human NTHL1 bind DNA in the same manner as its bacterial orthologs?

This work portrayed structural differences between hNTHL1 compared to its
bacterial homologs. These insights reshape how we understand substrate recognition by
hNTHL1. It is critical moving forward to obtain a NTHL1-DNA co-complex model, to
verify our hypothesis that hNTHL1 binds to its substrate in the closed form, as seen in
homologs. The conformational change of hNTHL1 may confound co-complex
crystallization, by introducing conformational heterogeneity to reaction mixture during
crystal nucleation and growth. That said, two crystal hits were obtained, diffracting to
atomic resolution. The crystals were impossible to reproduce, however, and the
associated datasets impossible to solve by molecular replacement. Screening the SeMet
variant with alternate DNAs would be justified, given this experience. The quality of the
diffraction data sets obtained for the putative complex crystals were extremely high and
could likely have been solved by SAD phasing via selenium atoms. A second approach
might lean on our assertion that reducing the length of the linker region imparts the
closed conformation. The chimeric sequence from EcoNth severely inhibited the DNA
binding ability of hNTHL1, but alternate sequences inserted to this region might balance
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the conformational equilibrium in our favor, without diminishing DNA binding to the
same great extent.

4.2.2 How does NTHL1 use interdomain rearrangement in substrate recognition?

The NTHL163 crystal structure revealed an open conformation that is pivotal
in our understanding of how this group of glycosylases recognize their substrates. Golan
et al showed that EcoNei exhibits two conformations, an open state in the absence of
DNA, and a closed state when bound to DNA (Zharkov, Golan et al. 2002, Golan,
Zharkov et al. 2005). UDG was shown to have a more modest 10o “pinching” together of
the two domains (Parikh, Mol et al. 1998). All of the other previous crystal structures
describe DNA glycosylases as rigid enzymes, with little difference between the apo and
bound state (Figure 1-5) (Doublie, Bandaru et al. 2004, Baba, Maita et al. 2005, Faucher,
Robey-Bond et al. 2009, Imamura, Wallace et al. 2009, Duclos, Aller et al. 2012, Pidugu,
Flowers et al. 2016, Zhu, Lu et al. 2016). There have recently been numerous
fluorescence studies in solution, demonstrating conformational rearrangements in OGG1,
NEIL1, Nei, and Fpg (Koval, Kuznetsov et al. 2004, Kuznetsov, Koval et al. 2005,
Kuznetsov, Koval et al. 2007, Kuznetsov, Koval et al. 2007, Kuznetsov, Koval et al.
2012, Kuznetsov, Vorobjev et al. 2012, Kuznetsov, Kuznetsova et al. 2014, Kuznetsova,
Kuznetsov et al. 2014, Kladova, Kuznetsova et al. 2017, Kladova, Grin et al. 2019,
Tyugashev, Vorobjev et al. 2019). The fluorescent work on Nth suggests that the
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bacterial homolog does not undergo interdomain rearrangements (Kuznetsov, Kladova et
al. 2015).

One powerful way of studying the conformational change in hNTHL1 would be
to use the endogenous quenching of the [4Fe4S] cluster to observe the opening and
closing of the enzyme on DNA. The [4Fe4S] cluster within NTHL1 can be exploited to
quench DNA that is labeled with Cy5, a far-red fluorescent dye, thus removing the
challenge of labeling the protein with a fluorescent tag or unnatural amino acid (Honda,
Park et al. 2009, Pugh, Honda et al. 2010). This experimental design would reveal if the
[4Fe4S] cluster domain of hNTHL1 contacts the DNA upon binding of substrate (Figure
4-1). The 23Å difference between the open and closed states should be large enough to
observe a quenching effect. This assay could also be used to accurately measure Kd
(Pugh, Honda et al. 2010). The gel-based assays reported here can overestimate the Kd of
an enzyme, because proteins are not experiencing true equilibrium conditions, and the
complex can be lost while running the gel. Using this FRET based approach would allow
for comparison disease-associated and rationally designed variants of hNTHL1 under true
equilibrium conditions.

To study the conformational change in the absence of DNA, a fluorophore will
need to be placed on the enzyme itself, in the six-helical barrel domain. The [4Fe4S]
cluster may be able to act as an endogenous quencher again, or perhaps a second
fluorophore may need to be attached in the [4Fe4S] cluster domain, establishing a Fӧster
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resonance energy transfer (FRET) model. One foreseeable challenge is that fluorophores
are typically attached through cysteines, and hNTHL1 harbors a [4Fe4S] cluster that is
coordinated by four cysteines. There exists experimental precedence, however, that the
cysteines should be non-reactive from their respective positions coordinating the [4Fe4S]
cluster (Goetzl, Teutloff et al. 2017). Development of the endogenous quenching or
FRET model would allow us to monitor the conformation of hNTHL1 throughout its
catalytic cycle, in the presence and absence of DNA, and in solution at true equilibrium.

If the quenching model on DNA was established, the experiment could be
extended to a pseudo-three channel approach, in order to examine hNTHL1 as it moves
along the DNA in the presence of other proteins (Honda, Park et al. 2009, Pugh, Honda et
al. 2010). For example, the hand off between hNTHL1 and hAPE1 could be observed by
tagging hAPE1-Cy5 and the DNA oligo with-Cy3, (green dye). When only hNTHL1 is
bound to the DNA, there should be a quenching effect of the Cy-5. When only hAPE1 is
bound to the DNA lesion, there will be a FRET signal. If both hAPE1 and hNTHL1 are
bound near the DNA lesion, there should be a synergistic decrease in emission due to
quenching by the [4Fe4S] cluster. The development of a single molecule
quenching/FRET model, exploiting the [4Fe4S] cluster of NTHL1, will allow for
quantification of DNA binding, conformation change studies, and protein-protein
interaction studies on DNA.

142

4.2.3 What is the basis of apparent cooperativity in hNTHL1?

Cooperativity has been observed in hNTHL1, but not in the bacterial homologs
(Liu, Choudhury et al. 2003, Cannan, Tsang et al. 2014). A dimer interface has been
proposed as a basis for cooperativity, but multimerization was not identified in the crystal
structures. The N-terminal extension appears to contribute to the apparent cooperativity
(Liu, Choudhury et al. 2003), but the mechanism of action is unclear. The apo-crystal
structures did not reveal a definitive dimer interface, but the protein construct lacks the
N-terminal extension which may be essential. The hNTHL163 (open conformation) and
hNTHL163 chimera (closed conformation) models exhibit identical two-fold
crystallographic axes in different space groups (P63 and P212121, respectively). However,
the dimer interface prediction databases of EPPIC and PISA characterize the putative
dimer interface as most likely crystallographic and very weak (Krissinel and Henrick
2007, Bliven, Lafita et al. 2018). To test the putative dimer interface experimentally, I
created a hNTHL1 construct with 5 residues mutated at putative interface to mimic the
residues present in EcoNth. When running these proteins on a native PAGE gel, a
banding pattern similar to that observed of parental hNTHL1 was observed, suggesting
the residues were not encouraging multimerization in hNTHL1. Multimerization of
hNTHL1 could alternately be observed in the fluorescence quenching assays described
above, given the capacity of these experiments to more accurately measure rate and
binding constants.
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The scenario most consistent with the present data dictates that the elusive
hNTHL1 dimer is unlikely to exist. The underappreciated monomeric cooperativity
model explains the apparent cooperativity seen in hNTHL1, but not in the bacterial
homologs, as an attribute of the conformations determined here by X-ray crystallography.
Monomeric cooperativity requires a conformational change that is slower than product
release (Porter and Miller 2012). To establish this kinetic model in hNTHL1 beyond a
shadow of doubt, characterization of the gross conformational change of hNTHL1 would
need to be elucidated in solution via single molecule studies such as: Trp fluorescence,
endogenous quenching, or FRET. Kinetic cooperatively could be verified if a
conformational step in the catalytic cycle proved to be rate limiting overall.

4.2.4 How does hNTHL1 chimera behave in human cells?

We have shown biochemically that the flexibility between the domains of
hNTHL1 is crucial for DNA binding in vitro, but how does this feature contribute to
genomic stability in human cells? MCF10A cells have been used to evaluate hNTHL1
variants previously (Galick, Kathe et al. 2013). NTHL1 knock out MCF10A human
breast epithelial cells could be generated via crispr/cas9, and partially complemented with
the crispr-resistant hNTHL1 chimera variant. Various hallmarks of DNA disrepair could
be quantified, such as: chromosomal abnormalities, micronuclei, γH2AX foci formation,
sensitivity towards radiation or chemotherapeutics, etc. If abnormalities were observed, it
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would suggest that the conformational change is necessary for wild-type hNTHL1
function in cells.

4.2.5 Critical role of NTHL1 in C. elegans
Genome wide sequence analysis of the C. elegans genome has identified a
minimalist BER pathway. To date, only two glycosylases have been identified: uracil
DNA glycosylase (UNG-1) and NTHL1 (Morinaga, Yonekura et al. 2009, Fensgard,
Kassahun et al. 2010). Furthermore, the mammalian BER DNA polymerase, DNA
polymerase β (pol β), is not present in the C. elegans genome (Asagoshi, Lehmann et al.
2012). It has been shown that DNA polymerase θ (pol θ) can substitute for pol β
(Yoshimura, Kohzaki et al. 2006) and is the main BER polymerase in C. elegans
(Asagoshi, Lehmann et al. 2012). The lack of redundancy in C. elegans BER pathway
creates an ideal model organism for studying the BER enzymes in vivo, specifically the
pol θ mediated BER pathway, as little is known about this alternate mechanism
(Asagoshi, Lehmann et al. 2012).

It is believed that members of the BER pathway act in a concerted mechanism to
ensure that double-strand breaks do not occur after the removal of the damaged base
(Hill, Hazra et al. 2001, Liu and Roy 2002, Nazarkina Zh, Khodyreva et al. 2007). It has
also been shown that hNTHL1 has a quicker turnover rate on DNA containing Tg:A in
the presence of hAPE1, suggesting that there is at least a functional interaction between
the two enzymes (Marenstein, Chan et al. 2003). This interaction may be enzyme145

mediated or DNA-mediated. NTHL1 kinks the DNA upon binding, and this distorted
DNA shape may recruit APE1. The N-terminal extension of hNTHL1 may potentially be
involved in protein-protein interactions. By making CRISPER/Cas9 knock-ins of
CelNTH1 with varying lengths of the N-terminal extension, we could determine if the
recruitment of downstream BER enzymes is mediated by the N-terminal extension of
CelNTH1. The N-terminal extension is shorter in CelNTH1 than hNTHL1 but is required
for activity in vitro (Morinaga, Yonekura et al. 2009). CelEXO-3 E68A (C. elegans
homolog to hAPE1) was shown to form a complex with DNA containing a 3’- aldehyde,
the β-elimination product of CelNTH1, and at least one other unknown protein (Shatilla,
Ishchenko et al. 2005). A knock-out endogenous CelEXO-3 and compliment with
CelEXO-3 E68A, will allow for identification of the missing protein component of the
EXO-3 E68A-DNA complex, via immunoprecipitation and mass spectrometry.
Identifying the missing protein component of the EXO-3 E68A-DNA complex will help
elucidate the concerted mechanism of the BER pathway and shed insight into BER in
humans. C. elegans is an ideal model organism to study BER that is initiated by NTH1,
and that is pol θ mediated. The lack of redundant glycosylases in C. elegans allows for a
rather straightforward interpretation of phenotypes and genotypes observed when NTH1
is perturbed.
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4.3 TLP Future Directions

4.3.1 How is the rotated base stabilized in MsTLP?

We identified a rotation of the guanine in the activation site after guanylation via
X-ray crystallography. Upon examination of the activation nucleotide binding site, four
residues were identified in base stabilization: Tyr 40, Phe 44, Met 48, and Asn 139.
Biochemical activity assays can be performed to look at both activation of the tRNA and
nucleotidyl transfer in MsTLP with mutations of these four residues. In S. cerevisiae
THG1, the variant N157A (corresponding to MsTLP Asn 139), was shown to have
significantly less G-1 activity compared to wildtype (<3%). The variant was also able to
partially complement THG1-/- yeast. It was concluded that Asn 157 is significant in the
function of THG1 (Jackman and Phizicky 2008). Since, this Asn interacts with the
guanine in the nucleotide binding site in MsTLP, we would see a more severe inhibition
if this stabilization is critical to nucleotidyl transfer. To further characterize the
stabilization event, activation of the tRNA can be studied in the presence of ATP and
ITP. Both ATP and ITP will be unable to form the specific hydrogen bond with Asn 139,
which contributes to the preference for GTP in MsTLP as the activating nucleotide.
Ideally, one of these mutants could provide a separation of function variant, where TLP
stalls in the guanylated state, because movement of the two phosphates of the activated
tRNA is impeded. Nucleotidyl transfer would clearly be sterically inhibited in such a
variant.
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4.3.2 Does base rotation occur in THG1?

To determine if base rotation occurs after activation in yeast or human THG1,
X-ray crystallography could be used to visualize the adenylated intermediate.
Superposition of yeast and human THG1 (PDB ID: 3WBZ and 3OTB, respectively) show
that Asn 46 (Tyr 40 in MsTLP) makes a hydrogen bond with N1 of the rotated guanine.
The hydrogen bond could form with purines, but not pyrimidines, suggesting that base
rotation of adenine is possible in THG1. The variant ScTHG1 N46A was shown to have
22% of the G-1 addition activity relative to WT THG1. N46A also complements THG1-/yeast, suggesting that N46 provides adequate THG1 activity for viability (Jackman and
Phizicky 2008).

4.3.3 Can THG1 be targeted as an antifungal?

THG1 is an essential enzyme in yeast, but not humans, and therefore could be
targeted as an antifungal (Gu, Jackman et al. 2003). If a nucleotide analog could be
designed that trapped the adenylated tRNA due to steric occlusion of the base, cell death
would result due to the lack of tRNAHis maturation (Gu, Jackman et al. 2003, Gu, Hurto
et al. 2005). Having a greater understanding of the reverse polymerization mechanism
would allow for targeted drug design. If hpRNA were able to be soaked into the yeast
THG1 crystals, then time course crystallography could reveal the intermediates in a
sequential manner. These in-depth studies of reverse polymerization might reveal details
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of the nucleotidyl transfer step which we have not been captured in prior crystallographic
studies.
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4.4 Figures

Figure 4- 1: Fluorescence quenching experimental design
To look at the conformational change in solution, Cy-5 dye (star) can be
attached to the DNA oligo on the strand opposite the lesion (lightning bolt). When
hNTHL1 binds to the DNA oligo and moves towards the lesion, the [4Fe4S] cluster will
quench the Cy-5 dye. The quenching spectrum will have to be deconvoluted to determine
quenching due to conformational change vs. hNTHL1 binding. The graphs on the right
show a simplified version of the expected read out for parental hNTHL1, which will
undergo a conformational change upon binding, and the hNTHL1 chimera, which is
severely inhibited at DNA binding and therefore very little quenching should be
observed.
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